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Summary 
This study focuses on the development of an immobilized enzyme-based reactor for 
the chemo-enzymatic preparation of coenzyme A (CoA) analogues. The concept is 
based on published research proving that CoA biosynthetic enzymes can be used to 
catalyze the transformation of chemically-synthesized pantetheine analogues to their 
related CoA analogues. The three CoA biosynthetic enzymes that are used to 
catalyze the transformation reaction are pantothenate kinase (CoaA), 
phosphopantetheine adenylyltransferase (CoaD) and dephospho-coenzyme A kinase 
(CoaE). 
In this study we discuss the construction of fusion proteins of these three biosynthetic 
enzymes from two different bacterial sources (Escherichia coli and Staphylococcus 
aureus) with a cellulose binding domain (CBD) in order to achieve their 
immobilization on cellulose. Out of the eight biosynthetic enzyme combinations that 
can possibly be made up by these six CBD-fusion proteins we identified two 
combinations of three proteins that were fully characterized for their ability to 
transform the natural substrate and a substrate analogue into CoA and a CoA 
analogue respectively. One of these combinations is subsequently used in the 
construction of batch- and column-based reactors that are successfully employed in 
the preparation of two CoA analogues. This demonstrates that multi-enzyme 
reactors based on CBD-fusion proteins embody a viable strategy for the production 
of CoA and its analogues. 
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Opsomming 
Hierdie studie fokus op die ontwikkeling van 'n ge·immobiliseerde ensiem-gebaseerde 
reaktor wat gebruik kan word om analoe van koensiem A (KoA) chemo-ensimaties te 
berei. Die konsep is gebaseer op bestaande kennis wat KoA biosintetiese ensieme 
gebruik om die transformasie van chemies-gesintetiseerde pantete"ien-analoe na hul 
verwante KoA-analoe te kataliseer. Die drie ensieme wat nodig is om die 
transformasie te kataliseer is pantotenaatkinase (CoaA), fosfopantete"ien-
adenielieltransferase (CoaD) en defosfo-koensiem A-kinase (CoaE). 
In hierdie studie bespreek ans die versmelting van hierdie drie KoA biosintetiese 
ensieme afkomstig van twee verskillende bakteriele bronne (Escherichia coli en 
Staphylococcus aureus) met 'n sellulose-bindingsdomein (SBD) om sodoende die 
ensieme se immobilisering op sellulose te bewerkstellig. Vanuit die agt biosintetiese 
ensiemkombinasies wat moontlik saamgestel kan word uit die ses SBD-
fusieprote"iene, identifiseer ans twee kombinasies van drie ensieme wat ten volle 
gekarakteriseer is vir hulle vermoe om die natuurlike substraat en 'n 
substraatanaloog om te skakel na KoA en 'n KoA analoog onderskeidelik. Een van 
hierdie kombinasies is vervolgens gebruik om lot- en kolomreaktors saam te stel wat 
suksesvol aangewend is om twee KoA analoe te berei. Hierdie bevinding 
demonstreer dat multiensiemreaktore wat op SBD-fusieprote"iene gebaseer is 'n 
lewensvatbare strategie is om KoA en sy analoe mee te produseer. 
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Chapter 1 
Coenzyme A: its Biosynthesis and Utility 
1.1 Introduction 
The research presented in this thesis was aimed at the development of a new 
method for the preparation of analogues of Coenzyme A (CoA), a ubiquitous 
biological cofactor. As an introduction, we will first provide background information 
on CoA, focusing on its biosynthesis and the variety of applications of its currently 
available analogues. 
CoA is present in all living organisms, where it acts as an essential cofactor to many 
enzyme-catalyzed conversions. Based on a survey of the BRENDA database it is 
involved in approximately 9% of all enzymatic reactions ( 1). The molecule was 
discovered in 1945 by Lipmann et. al. and about ten years later its structure was 
determined by Baddiley (Figure 1.1) (2, 3). The pantetheine moiety of CoA is derived 
from L-cysteine and pantothenic acid, which is also known as vitamin Bs. 
Pantetheine is the final precursor of the cofactor that can be taken up by cells ( 4). 
NH2 
0 (=(; 
H0-~-0~ 
Ho-~-o ? OH b- O= P.- OH 
Figure 1.1: Structure of Coenzyme A {CoA). Pantetheine is the final precursor of CoA that can be 
taken up by cells. 
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Chapter 1 - Coenzyme A: its Biosynthesis and Utility 
In recent years a great diversity of CoA analogues has been developed as valuable 
research tools, as they were being used as inhibitors, molecular probes and protein 
labels. Such applications of CoA analogues have increased the scope and utility of 
these molecules, and therefore have caused renewed interest in the technologies 
whereby CoA and its analogues are prepared. 
1.2 The CoA biosynthetic pathway 
CoA has been known for more than fifty years but the enzymes that are responsible 
for its biosynthesis have only recently been discovered and characterized ( 4-6). The 
biosynthesis of CoA is dependent on five enzymes. The enzymes and their 
substrates are presented in Figure 1.2. 
In the first step of the CoA biosynthetic pathway pantothenate kinase (PanK; CoaA) 
phosphorylates the vitamin precursor pantothenic acid 1.2 to form 4'-
phosphopantothenic acid 1.3 (7). ATP is the phosphate donor in this step. In the 
second step 1.3 is activated via a coupling reaction to L-cysteine with the 
consumption of either CTP or ATP. The enzyme involved in this reaction is 
phosphopantothenoylcysteine synthase (PPC-S; CoaB). The product of the second 
step in the pathway is 4'-phosphopantothenoylcysteine 1.4. The third step in the 
pathway is a decarboxylation reaction. The enzyme assisting the reaction- is 4'-
phosphopantothenoylcysteine decarboxylase (PPC-DC; CoaC) and the product of 
the reaction is 4'-phosphopantetheine 1.5. In the penultimate step dephospho-CoA,. 
1.6 is formed by the transfer of an AMP moiety from ATP to 1.5 by 
phosphopantetheine adenylyltransferase (PPAT; CoaD). Inorganic pyrophosphate is 
a byproduct of this reaction. In the final step phosphorylation of the 3'-hydroxy group 
of dephospho-CoA 1.6 yields Coenzyme A 1.1 (8, 9). This step utilizes ATP and is 
catalyzed by dephospho-CoA kinase (DPCK; CoaE). 
All of the enzymes constituting this pathway has been characterized and expressed 
in human· and bacterial systems. The enzymes are currently used for the chemo-
enzymatic synthesis of CoA analogues. 
2 
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1.3 The function of CoA 
CoA acts mainly as an acyl group carrier in various enzyme-catalyzed reactions ( 10). 
Despite its complex appearance it is functionally a very simple molecule. The thiol, 
or sulfhydryl group, is the active part of the molecule. It reacts with the activated 
carboxylate groups of various carboxylic acid or aldehyde substrates to form 
thioesters, as shown in Figure 1.3. Acetyl-CoA is the most common of the CoA 
thioesters. Transfer of an acyl group from a thioester can proceed by either one of 
the two general methods which are described below (9). 
0 
CoA-S~R 
Figure 1.3: The general formation of acyl-CoA thioesters. A thioesterification reaction between 
CoA and a carboxylic acid derivative. The carboxylic acid is normally activated before the coupling 
reaction can take place. R represents the main chain of the carboxylic acid. 
1.3.1 Acyl-CoA thioesters as electrophiles 
Acyl-CoA thioesters can act as electrophiles in the attack of a non-carbon 
nucleophile on the electrophilic carbonyl of the acyl group (Figure 1.4 ). These 
reactions are mostly catalyzed by acyltransferases. The nucleophiles are usually 
alcohols and amines thus leading to the formation of esters and amides. 
0 
CoA ... s~( R 
e Nu 
a: N~ as an alcohol 
b: Nu8 as an amine 
+ CoASH 
+ CoASH 
Figure 1.4: Nucleophilic attack on the electrophilic carbonyl group of an acyl-CoA thioester. 
The nucleophiles are either alcohols (a) or amines (b). 
4 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 1 - Coenzyme A: its Biosynthesis and Utility 
1.3.2 Acyl-CoA thioesters as nucleophiles 
Acyl-CoA thioesters can also react as nucleophiles in reaction with carbonyl-based 
electrophiles, leading to the formation of new carbon-carbon bonds (Figure 1.5). The 
nucleophilic thioester attacks the electrophilic carbonyl groups of ketones, aldehydes, 
and other thioesters. The Claisen enzymes that catalyze these reactions are named 
as such due to the Claisen condensation reaction mechanism through which the 
activation takes place. 
0 
jl ----- CoA ... s~R CoA,8, GR 
( R" 0 
\..E$ 
Figure 1.5: Nucleophilic attack by the deprotonated a-carbon of an acyl-CoA thioester. These 
reactions are catalyzed by Claisen enzymes. The electrophile usually is a carbonyl group, aldehyde, 
ketone or another thioester. 
1.4 Application of CoA analogues 
A wide variety of CoA analogues have been developed as valuable mechanistic 
probes, enzyme inhibitors and protein labels. An overview of some of these 
analogues and a short discussion of their applications follows below. 
1.4.1 Reactivity probes and inhibitors 
Table 1.1 presents a variety of CoA analogues that have been developed as 
reactivity probes and inhibitors of biological reactions. We will shortly discuss the 
specific applications of each of these. 
Both the epoxide-substituted CoA analogues and the unsaturated CoA thioesters are 
known inhibitors of acyl-CoA dehydrogenases (11). The citrate synthase inhibitors 
are mimics of acetyl-CoA, the natural substrate of this enzyme. They imitate the 
formation of the possible enol or enolate reaction intermediate that is formed in the 
presence of oxaloacetate ( 12). E. coli fatty acid biosynthesis is inhibited by the 
formation of an inactive acyl carrier protein (ACP) complex (10). Transfer of the 
5 
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modified phosphopantetheine moiety of CoA to the ACP leads to the formation- of an 
inactive covalently bonded enzyme-substrate complex. 
The histone acetyltransferase (HAT} domain of the p300 transcriptional co-activator 
catalyze the transfer of an acetyl group between acetyl-CoA and the e-amino lysine 
atom in histones and other proteins ( 13). The analogue shown in Table 1.1 known 
as Lys-CoA has the ability to block this activity, but the negatively charged phosphate 
groups on the molecule prevent it from crossing the cell wall. To increase cell-
permeability a cell permeable tag was linked to the analogue by formation of a 
disulfide bond (14). Once the molecule has entered the cell the bond is broken and 
the inhibitor is trapped inside. 
6 
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Epoxide substituted 
analogues 
0 
R = /,s~ 
0 
0 
R = /,s~ 
0 
Stereochemical 
probes 
Citrate synthase inhibitors ~ OH 
R - /-H2CXOH 
HQ OH 
R- /-H2CXH 
Antibiotic against 
Inhibitor of HAT p300 
R = 
R = 
E.coli 
/~ 
H 0 
I~ R = /......_S~N~NH2 0 H' NHAc 
Mechanistic probes 
R = ./"<) 
0 
0 
R=/,0~ 
1.7.1 
R= 
H /~Nn 
0 Cl 
Unsaturated 
thioesters 
0 0 
R= /,s~ 
0 CH2 
R = /,s~ 
0 CH3 
R= /,s~ 
(di)thiocarbonates 
and carbamates 
0 
R = /......_S)lO'.Et 
0 
R= /"S)l_N, H 
H 
0 
R = /,S)l_N~ 
H 4 
R = 
Table 1.1: Examples of CoA analogues that have been developed as enzyme inhibitors and 
mechanistic probes 
7 
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The two secondary alcohol stereochemical probes are reactivity probes used to 
determine the structure of the tetrahedral intermediate in the reaction of acetyl-CoA 
dependent acetyltransferases ( 15). 
Crotonyl-oxy-CoA 1. 7 .1 is used as a mechanistic probe of the reaction catalyzed by 
enoyl-CoA hydratase. This reaction concerns the syn-hydration of a,~-unsaturated 
fatty acyl-CoAs ( 16). The other three mechanistic probes are used for investigation 
of carrier protein (CP) mediated biosynthetic reactions by the inactivation of 
ketosynthases ( 17). 
The thiocarbonates and carbamates are examples of heteroatom-substituted acyl-
CoA analogues. They were used to determine the structural requirements of the 
substrate that prevents oxidation of the reduced flavin of the medium-chain acyl-CoA 
dehydrogenase ( 18). 
1.4.2 Reporter labels 
Acyl carrier proteins (ACPs) play and essential role in fatty acid, polyketide and non-
ribosome based peptide biosynthesis (17). These proteins are activated- by the 
transfer of the phosphopantetheine moiety of CoA to a conserved serine residue on 
the ACP itself (Figure 1.6). The activated form of the ACP is referred to as ho/o-ACP. 
The transfer reaction is catalyzed by a phosphopantetheinyl transferase (PPTase) 
enzyme. 
8 
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NH2 N~N 
0 ~ _Q__ ) 
II N N 
H0-6-0~ 
HO- P=O 0 OH 
I I 
O O=P- OH Cellu lar uptake 
CoA biosynthesis y H OHH 
Pantothenic acid 
(Vitamin Bs) 
'i? OH O'l'o.r-..._~O 
"o I\ ,r\,n 
HN~ 
SH 
Activated Acyl Carrier Protein 
(ho/o-ACP) 
Ho' ··~N~N'-./"sH 
0 0 
Coenzyme A 
Phosphopantetheinyl 
transferase 
Figure 1.6: Activation of acyl carrier proteins. The 4'-phosphopantetheine moiety from CoA is 
transferred to a serine residue on ACP. The transfer is mediated by phosphopantetheinyl transferase 
(PPTase) enzymes. 
Research by La Clair et. al. has shown that the PPTase from B. subtilis, known as 
Sfp, can catalyze the transfer of phosphopantothenamide moieties from various CoA 
analogues to ACPs, thus allowing the labelling of these proteins with fluorescent and 
affinity tags (Figure 1.7) (19). These labeled ACPs are named crypto-ACPs. In vivo 
and in vitro studies conducted in this regard have led to the development of a wide 
range of new CoA analogues of which some are presented in tables 1.2 and 1.3. 
The methodologies used in these studies are discussed below. 
9 
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OH 
":.<-~~~  
0 0 
Labeled pantothenamide 
(Reporter or Probe) 
In vitro 
Preparation of CoA analogue 
or 
In vivo 
Cellular uptake CoA biosynthesis 
Labeled Acyl Carrier Protein 
(crypto-ACP) 
NH2 
N~N 
0 ~ J__ __ J
II N N 
Ho-ro~ 
HO-P=O 0 OH 
I I 
o O=P-OH y OH ~ 
HO'· ·~~~~~ 
0 0 
CoA analogue 
Sfp 
Figure 1.7: In vitro and in vivo labelling of ACP with phosphopantothenamide moieties from 
CoA analogues carrying fluorescent or affinity labels. The labeled ACP is in this case referred to 
as a crypto-ACP. Sfp is the promiscuous PPTase that catalyze the transfer of the 
phosphopantothenamide moiety from CoA to ACP. 
10 
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AFFINITY LABELS 
O')-N .. ~ 
HN,.,9s 
O')-N .. ~ 
HN,,,Q 
OH 
03 OJ H~ HO 0 0 0 NH NH 
< 
HN HN,1 ) HN 
o f o HN < NH 0 0 ( 0 ) 
s ~ 0 R- ~ 
" 
( - /"s o R= HN 
0 
o ~o NH R=/~o 1.7.3 1.7.6 02 
1.7.2 R=;(s~o 0~0 
1.7.4 s 
R='< 
1.7.5 
Table 1.2: Affinity labels used for the purification of specifically targeted proteins 
11 
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HO 
R= 
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1.7.14 
FLUORESCENT LABELS 
1.7.11 
1.7.9 
opo 
R= 1- s 
1.7.15 
1.7.12 1.7.13 
0 
H 
R=\~N 
0 
1.7.10 
O=S=O 
I HN\ 
0 N 0 R=J-Y 
1.7.16 
Table 1.3: CoA analogues with fluorescent tags used for labelling of targeted ACPs 
12 
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1.4.2. 1 In vivo protein labelling 
To achieve labelling of ACPs inside living cells one needs to synthesize 
pantothenamides that can cross the cell wall. Once inside the cell these molecules 
are then accepted into the CoA biosynthetic pathway and the 
phosphopantothenamide moiety of the resulting CoA analogue is subsequently 
transferred to an ACP. 
Recent studies by Burkart et. al. has focused on the development of such 
phosphopantothenamides and successful in vivo protein labelling has been achieved 
with the coumarin based CoA analogue 1.7.10. (20). 
1.4.2.2 In vitro and cell surface protein labelling 
For the purpose of in vitro protein labelling a CoA analogue can be prepared by any 
synthetic or chemo-enzymatic method, and only afterwards added to cell free media 
containing ACP and PPTase. The transfer of the phosphopantothenamide moiety of 
the CoA analogue to ACP is subsequently catalyzed by the PPTase. 
Burkart et. al. developed a range of affinity and fluorescent reporter labels 1. 7 .2-1. 7 .5 
and 1.7.11-1.7.16 based on maleimides for the labelling of ACPs in vitro (19). He 
specifically chose maleimides due to their particular reactivity towards sulfhydryl 
groups, which is ideal for reactions with CoA. 
Affinity labels can be used to purify labeled proteins by recognition of receptor 
proteins. It can also be used to visualize carrier proteins via Western blotting. Biotin 
and mannose have been used for the development of CoA containing affinity tags. 
These tags are then transferred to ACPs and receptor proteins are used to recognize 
and purify them from solution. The receptor proteins for biotin labels used in 1. 7.3-
1. 7 .6 are avidin/streptavidin and for the mannose label used in 1.7.2 it is 
concanavalin ( 19). 
13 
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Research involving in vitro protein labelling is currently at a more advanced stage 
than in vivo labelling. In a study by Yin et. al. published in 2004 they have reported 
the fusion of a protein of interest and an ACP, thus allowing the labelling of these 
proteins by phosphopantetheine moieties from CoA analogues through their transfer 
to the ACP (Figure 1.8) (21). 
Labeled Fusion Protein 
(In vitro or on cell surface) 
NH2 
N~N 
0 ~ JL.) 
II N N 
H0-6-0~ 
HO-P=O 0 OH 
I I O O=P- OH y OH ~ 
HO'. -~~~~~ 
0 0 
Coenzyme A analogue 
(Reporter or Probe) 
Phosphopantetheinyl 
transferase 
Figure 1.8: In vitro labelling of targeted proteins through the post-translational modification of 
ACP-fusion proteins. The phosphopantothenamide moiety of a CoA analogue is transferred to an 
ACP that is fused with the protein of interest. Transfer is mediated by the promiscuous PPTase. 
This technology has now not only been applied to in vitro studies, but also to the 
labelling of proteins on cell surfaces (22). The ACP/PPTase pair from E. coli was 
used in a study to achieve the specific labelling of proteins on the cell surface. The 
ACP was expressed as a C-terminally attached protein to the a-agglutinin receptor, 
the protein of interest. These studies were conducted in S. cerevisiae. The affinity 
and fluorescent labeled CoA analogues 1.7.6-1.7.9 were used in this study. 
Incubation of the modified yeast cells with 6 x His-tagged PPTase and the respective 
14 
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CoA analogues resulted in a clear fluorescent signal surrounding each of the cells 
surfaces. 
1.5 Outline of this study 
Considering the great number of existing CoA analogues and the wide scope of their 
applications the development of a method that allows the efficient and inexpensive 
synthesis of such analogues have become critical. In chapter 2 we will review the 
diversity of methods that are currently available to prepare all known CoA analogues, 
and indicate the advantages and disadvantages of each. 
Our laboratory has been intensely involved in this area, focusing on the development 
of chemo-enzymatic based methods to prepare CoA analogues. We have been 
specifically interested in methodologies that make use of CoA biosynthetic enzymes 
which have been immobilized on a solid support, with the specific aim of developing 
enzyme-based reactors while also increasing the usable lifetime of the proteins. No 
published reports currently exists that makes use of such technology. 
This thesis will describe our most recent achievements in this regard. It will build on 
previous studies that attempted to fuse the CoA biosynthetic proteins to a so-called 
CBD, or cellulose binding domain, with the aim of subsequently immobilizing these 
fusions on cellulose as a cheap solid support. Chapter three describes our efforts 
towards the construction, expression and purification of six novel fusion proteins, 
followed by a full characterization report of these proteins in chapter four. In the final 
experimental chapter we present and prove the concept of implementing these 
proteins in a newly developed strategy that utilizes a bioreactor for the continuous 
production of CoA analogues. Chapter six is a summary of all our achievements and 
contains a short discussion of our future research plans. 
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Chapter 2 
A Review of the Available Methods for the Preparation of 
Coenzyme A Analogues 
2.1 Introduction 
There is a great diversity of methods currently available for the preparation of CoA 
and its analogues. For the purpose of this review we have divided these methods 
into two categories, namely synthetic methods and chemo-enzymatic methods. 
Chemo-enzymatic is a term used to describe methods that are not based on pure 
chemical synthesis but also include enzymatic transformations. This review will 
specifically focus on the drawbacks and advantages of the various methods that are 
currently in use. 
2.2 Chemical synthesis of CoA Analogues 
2.2.1 Retrosynthesis of CoA 
The synthesis of CoA can easily be rationalized in terms of a retrosynthesis of the 
molecule, as shown in Scheme 2.1. The two parts that form the basic structure of 
the molecule is the adenosine and 4' -phosphopantetheine moieties ( 1). Synthesis of 
the adenosine moiety is very challenging and is therefore avoided by using an 
adenosine diphosphate molecule 2.1 (2). On the other hand 4'-phosphopantetheine 
1.5 is relatively easily synthesized from pantothenate and cysteamine (3). A more 
recent route, proposed by Burkart et. al., also allows synthesis starting with 
pantolactone, J3-alanine and cysteamine ( 4). 
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OH 
I 
HO-Pi=O 
H~~'-"j(~-../'-sH 
OH 
HO~OH 
0 
0 0 
1.5 
f3-alanine 
il 
+ 
Original route 
cysteamine 
NH2 
N~N 
0 ~ .Jl .. ) 
II N N 
HO-Pi-O--y---0---j 
OH ~ ? OH 
O=Pi·OH 
OH 
2.1 
pantothenate 
Scheme 2.1: Retrosynthesis of Coenzyme A 
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2.2.2 Starting from pantetheine derivatives 
The two retrosynthetic routes allow the introduction of modifications in the 4' -
phosphopantetheine moiety of CoA. Pantetheine derivatives can be prepared by the 
reaction of an activated pantothenic acid derivative with a cysteamine analogue, or 
the reaction of pantolactone and a ~-alanylcysteamine analogue ( 1). From this the 
phosphopantetheine analogue can be prepared and then the same strategy is 
followed as with the synthesis of natural CoA to prepare the desired analogue. 
2.2.3 Total chemical synthesis of CoA 
CoA was first synthesized via the method reported in 1959 by Moffatt and Khorana 
(3). Scheme 2.2 summarizes the three main steps of their approach. The reaction is 
based on a coupling between phosphopantetheine 2.2 and an activated adenosine 
diphosphate 2.3. 
There are three drawbacks to this strategy. The synthesis of the adenosine moiety of 
CoA is very difficult and is therefore avoided by starting with 2'(3'),5'-cyclic ADP. 
Forming the pyrophosphate bridge is also problematic. 2'(3'),5'-Cyclic ADP needs to 
be activated before it reacts with 2.2. The activation is achieved via a coupling 
reaction to morpholine to form 2.3. The final step of this synthesis is the 
phosphorylation of the adenosine group. Unfortunately, hydrolysis of 2.4 causes 
formation of CoA 1.1a and iso-CoA 1.1b in roughly equal amounts. /so-CoA is the 2'-
phosphate isomer of the natural molecule. Separation of these two molecules is 
difficult and tedious, and this final step is thus one of the major drawbacks of the pure 
synthetic preparation of CoA. 
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NH2 
N-AN 
0 ~ JL .. J I\ II 0 N N 
0 N-P.-o-yO~ 
\__! 6H ~/\ 
o, /0 
R,., 
HO 'o 
2.3 
+ 
OH H H =03PO~N~N ............... SH 
0 2.2 0 
2.4 1.1 
a R'= P03 =, R = H 
bR'=H, R=P03= 
Scheme 2.2: The total chemical synthesis of CoA as published by Moffatt et. al. in 1959 
2.2.4 Modifying and derivatizing natural CoA 
2.2.4.1 Derivatization of the thiol group 
Analogues of CoA can be synthesized from the natural molecule by derivatization of 
the reactive terminal thiol group of native CoA. Various thioesters have been 
synthesized by reactions between CoA and acylating reagents. Some of these 
acylating reagents include activated acid derivatives, symmetric and mixed 
an hydrides and acyl imidazoles ( 1). 
An example of an acylation reaction by an acyl imidazole is the synthesis of radio-
labeled acetyl-CoA 2.5a and propionyl-CoA 2.5b (5). The sodium salts of acetate 
and propionate were reacted with carbonyldiimidazole before the addition of reduced 
CoA (Scheme 2.3). 
CoASH 0 
,.. II 
imidazole CoA-S~R 
* 
2.5 
aR=H 
b R = CH2CH3 
Scheme 2.3: Synthesis of radio-labeled acetyl-CoA 2.Sa and propionyl-CoA 2.Sb. 
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Thioether analogues have also been synthesized. This was achieved by alkylation of 
the reactive thiol group of natural CoA. Examples of CoA thioethers include S-ethyl-
CoA 2.6a, S-octyl-CoA 2.6b and S-heptadecyl-CoA 2.6c ( 6, 7). These are all 
prepared by reaction of CoA with alkyl halides (Scheme 2.4). 
CoASH + C2HsX .. CoA-S~ a 
CoASH + CaH18X .. CoA-S~ b 
CoASH + C17H35X ... CoA-s~ c 
X =Cl, Br 2.6 
Scheme 2.4: Synthesis of thioether CoA analogues by alkylation. 
a-Haloketones have been used to synthesize CoA thioethers thus producing CoA 
derivatives with a methylene group inserted between the carbonyl group and the 
sulfur atom (Scheme 2.5) (8, 9). 
CoASH 
0 
-----·~ CoA-sJR 
Scheme 2.5: Synthesis of CoA thioethers with a methylene group inserted between the S-atom 
and the carbonyl group. 
2.2.4.2 Desulfo-CoA 
Some synthetic analogues are prepared by directly modifying the thiol group of CoA. 
Desulfo-coenzyme A 2. 7 is a CoA analogue that is prepared by reductively removing 
the terminal thiol group of natural CoA. A Raney nickel catalyst is used as reducing 
agent (Scheme 2.6). 
22 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 2 - A Review of the Available Methods for the Preparation of CoA Analogues 
CoA-S-H Ni(H) + H2 + NiS 
< 100°c 
Scheme 2.6: A general reaction scheme for desulfurization by a Raney nickel catalyst 
2.2.4.3 Dithioesters of CoA 
Another alternative synthesis is a reaction in which the oxygen in the thioester 
carbonyl is replaced by a sulfur atom ( 10). Lawesson's reagent (LR) was used to 
convert a phenyl thioester to a phenyl dithioester by simply refluxing it in the 
presence of toluene. LR is a very effective thionating agent of carbonyl compounds 
( 11). A transesterification reaction was conducted to yield the corresponding CoA 
analogue (Scheme 2. 7). 
0 
Q-s...)l__x + LR 
X=H 
X=F 
s 
toluene/reflux _. Q-s...)l__ X CoASH S _. II CoA-S~x 
Scheme: 2.7: Thionation of a carbonyl compound. Conversion of a thioester to a dithioester and 
the subsequent transesterification yields a CoA dithioester analogue. 
The major drawback of these methods involving the derivatization and modification of 
CoA itself in order to prepare its analogues is that they are all restricted to the 
preparation of one type of analogue. There is no general method available by which 
CoA can be modified or derivatized to prepare different kinds of analogues. 
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2.3 Enzymatic synthesis of CoA analogues 
2.3.1 Introducing Ribonuclease T2 
The first introduction of enzymes into the synthesis of CoA was in 1964 when 
Michelson presented a modification of the original method published by Moffatt and 
Khorana (Scheme 2.8) (2). 
Pyridine 
1) Ribonuclease T2 
2) f3-mercaptoethanol 
CoASH 
Scheme 2.8: The first chemo-enzymatic synthesis of CoA. 
The first modification he introduced was synthesizing P1-adenosine (2',3'-cyclic 
phosphate)-5'-p2-diphenylpyrophosphate 2.8 as a starting material. Using 2.8 
instead of 2.1 as starting material simplified the synthesis by eliminating the 
activation step that was necessary for formation of the pyrophosphate bridge in CoA. 
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2.8 was reacted with pantetheine 4',4'-bisphosphate 2.9 to form a disulfide 2.10 of 
the final intermediate from the original synthesis. In the final step Michelson 
introduced ribonuclease T2 to catalyze the selective hydrolysis of the 2',3'-cyclic 
phosphate, thus preventing the formation of isomers as in the original method. CoA 
disulfide was reduced with ~-mercaptoethanol to obtain CoASH (reduced CoA). 
Although this modified method was an improvement on the first synthesis proposed 
by Moffat and Khorana it could still not fully address the problems with the difficult 
synthesis of the adenosine moiety and the formation of the pyrophosphate bridge. 
2.3.2 Derivatization of CoA 
There are four enzymes that have been used for the derivatization of the CoA 
molecule to yield CoA ester analogues. Phosphotransacetylase assists the acylation 
of CoA by various acyl phosphates (Scheme 2.9). Carnitine acetyltransferase assists 
acylation of CoA with carnitines acting as acyl donors ( 12). 
0 0 
II 11 phosphotransacetylase 
R---'o" P~~:r 
O £N(CH3)3+ 
JI carnitine acetyltransferase R---'o co2- --------~ 
Scheme 2.9: Enzymatic acylation of CoA using acyl donors as substrates. 
CoA thioesters have also been formed by a direct coupling reaction between CoA 
and a carboxylic acid in a simple aqueous medium ( 1). These reactions were 
catalyzed by ATP utilizing enzymes, acetyl-CoA synthetase and acyl-CoA synthetase 
(Scheme 2.10). In both cases the ATP is hydrolyzed to AMP and pyrophosphate. 
Acyl-CoA synthetase may have more general usage since it accepts long chain fatty 
acids as substrates, whereas the versatility of acetyl-CoA synthetase is limited by its 
substrate acceptance (13-15). 
+ ATP acetyl-CoA synthetase or ., 
acyl-CoA synthetase 
0 )l_ 
R S-CoA 
Scheme 2.10: A general scheme for the enzyme-assisted acylation of CoA via a direct coupling 
reaction to a carboxylic acid. 
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2.3.3 Introducing CoA biosynthetic enzymes 
The drawbacks of the chemical synthetic strategy used for the synthesis of CoA 
forced researchers to investigate alternative methods of producing the molecule and 
its analogues. 
Analogues of CoA can be synthesized using isolated enzymes from the CoA 
biochemical pathway. The addition of the adenosine moiety and formation of the 
pyrophosphate bridge which was the main drawbacks of the original synthetic 
strategy could now be achieved in one enzymatic step. Further, no racemic mixture 
of the product is formed since specific hydrolysis yielding only the CoA isomer could 
be achieved·. 
2.3.3.1 Introducing phosphopantetheine adenylyltransferase (CoaD) and 
dephospho-CoA kinase (CoaE) 
In 1966 Stewart and Ball presented a method by which o-Oxypantetheine 4'-
phosphate was chemically synthesized and then enzymatically transformed to Oxy-
CoA (Scheme 2.11) ( 16). They isolated a bifunctional enzyme complex from beef 
liver containing phosphopantetheine adenylyltransferase (CoaD) and dephospho-
CoA kinase (CoaE) capable of this transformation. This method has been expanded 
to the production of various CoA analogues including desulfo-CoA 2. 7 which was 
previously produced by the Raney nickel reduction of CoA ( 17). 
CoaDE 
Scheme 2.11: Biosynthesis of Oxy-CoA. 
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In 1992 Martin and Drueckhammer presented a method based on the research of 
Stewart and Ball for the chemo-enzymatic synthesis of a CoA analogue synthon 
2.11a (18). 
A synthon is a template molecule that can very easily be modified to produce a 
number of related molecules. They used a phosphopantetheine analogue in which 
the amide bond furthest from the phosphate group was replaced by a thioester 
group. This was enzymatically transformed to the related CoA thioester analogue 
(Scheme 2.12). Brevibacterium ammoniagenes was the enzyme source for these 
reactions. 
By aminolysis of 2.11 a with various primary amines a variety of CoA and CoA ester 
analogues could be produced, but the very reactive terminal thiol group of the 
synthon caused problems. It formed unwanted disulfide bonds and caused 
interfering thiolysis reactions. To overcome this problem the thiol group was replaced 
by a methyl group forming a propyl thioester synthon 2.11b (19). 
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NH2 
N~N 
0 ~ J._ __ ) 
II N N H0-~-0~ 
HO-Pi=O OHOH 
0 
I 
HO-Pi=O 
OH 
ATP 
CoaE 
ADP 
2.11a X=NH,Y=S,Z=SH 
2.11b X =NH, Y = S, Z = CH3 
2.11c X=S,Y=NH,Z=CH3 
Scheme 2.12: Synthesis of the three CoA analogue synthons 2.11 a, 2.11 b and 2.11 c. 
A second generation CoA analogue synthon has later been developed in which the 
amide bond more distant from the terminal thiol group was replaced by a thioester 
2.11 c (20). A racemic phosphopantetheine analogue was synthesized. Thereafter 
enzymatic conversion to the corresponding CoA analogue was achieved using the 
same enzyme system as before. CoaD selectively yielded the natural S-isomer. 
Three new analogues were synthesized by this method, for the first time introducing 
modifications in the f3-alanylcysteamine moiety (Scheme 2.13). 
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Scheme 2.13: CoA analogues containing modifications in the p._alanylcysteamine moiety. The 
three analogues synthesized from the second generation CoA analogue synthon 2.11 c. 
2.3.3.2 Introducing pantothenate kinase (CoaA) 
2.3.3.2.1 Characteristics of bacterial pantothenate kinase (CoaA) 
Pantothenate kinase (CoaA), acts as the gate-keeper in the biosynthetic pathway of 
CoA. It catalyzes the ATP-dependent phosphorylation. of pantothenate which is the 
rate-controlling step of this pathway (21) . EcCoaA, pantothenate kinase isolated 
from E. coli, was the first pantothenate kinase enzyme to be extensively 
characterized and is considered the prototype of bacterial CoaA (22). 
EcCoaA lacks substrate specificity which makes it ideal for accepting various 
pantetheine derivatives. However, it is subject to feedback inhibition by CoA and its 
thioester analogues. This is due to competitive binding between CoA and ATP to the 
ATP binding-site on the protein (23). The disadvantage of feedback inhibition is that 
it prevents the use of in vivo and one pot in vitro methods for the overproduction of 
CoA or CoA thioesters. 
2.3.3.2.2 Pantothenate kinase (CoaA) in a step-wise synthetic strategy 
In more recent years the chemo-enzymatic synthesis of CoA analogues has 
developed to include CoaA as the first enzyme in the transformation process. By this 
method pantetheine derivatives can be chemically synthesized and then 
phosphorylated by CoaA to produce the corresponding phosphopantetheine 
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derivatives. This can further be transformed by CoaD and CoaE to yield the CoA 
analogue with a modified pantetheine moiety. 
ATP 
EcCoaE 
ADP 
NH2 
N-AN 
0 ~ Jl .. ) 
II N N Ho-ro~ 
HO-~=O ? OH 
O 0=6~0H 
H H O 
HO N~N~O~ 
0 0 
2.14 
5 steps 
EcCoaD 
ATP AMP+ PPi 
OH 
I 
HO-Pi=O 
ATP 
EcCoaA 
ADP 
~ H H O HO''·~N~N~O~ 
0 0 2.13 
Scheme 2.14: Chemo-enzymatic synthesis of Crotonyl-Oxy-CoA 2.14 starting from a 
chemically synthesized pantetheine derivative 2.12. 
One of the first analogues to be synthesized by this method was Crotonyl-Oxy-CoA 
2.14 (Scheme 2.14) (24). The pantetheine derivative 2.12 was synthesized from D-
pantothenic acid in 5 consecutive steps. Three separate enzymatic steps followed to 
obtain the final product. E. coli enzymes were used in this· reaction. Crotonyl-
oxypantetheine 2.12 was found to be an excellent substrate for EcCoaA. Pyruvate 
kinase and phosphoenol pyruvate was added to the separate steps for the recycling 
of ATP (25). Pyrophosphatase was added to the reaction catalyzed by EcCoaD to 
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hydrolyze the inorganic pyrophosphate (PPi) formed from the coupling reaction. The 
overall yield for the enzymatic part of the synthesis with purification after each step 
was 62%. 
2.3.3.2.3 A one-pot synthesis of CoA analogues 
In 2004 Nazi et. al. reported another improved strategy in which he proposed a one-
pot chemo-enzymatic synthesis, thus eliminating the purification step after each 
transformation (26). Enzymes from E. coli were purified before usage to eliminate 
the interference of possible side reactions. Each transformation reaction was 
followed by HPLC and the next enzyme added only after complete conversion by the 
previous one was achieved. 
Nazi also showed that complete conversion to the CoA analogue could be achieved 
by simultaneous addition of all three enzymes and the required amount of ATP to the 
pantetheine derivative, followed by a 90 min incubation period at 37°C. 
2.3.3.2.4 SaCoaA in a one-pot synthesis of CoA analogues based on a new 
CoA synthon 
Research from van Wyk and Strauss published in 2006 showed a new improved CoA 
analogue synthon from 2.11 b synthesized by Martin et. al. (27). They synthesized 
phenyl thiopantothenate via a one step transesterification reaction with unprotected 
pantothenic acid. SaCoaA, pantothenate kinase from S. aureus, together with 
EcCoaDE was used in a one pot reaction to catalyze the total conversion of the 
phenyl thiopantothenate to the CoA analogue synthon (Scheme 2.15). 
SaCoaA is the only known CoaA protein that is not feedback regulated by either CoA 
or CoA thioesters (28). It also shows a lack of substrate specificity (27). Thus by 
using SaCoaA this method allows one pot preparation of CoA analogues without the 
poor yield due to inhibition by the product. 
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SaCoaA,EcCoaD,EcCoaE 
ATP 
Scheme 2.15: Chemo-enzymatic synthesis of ethyldethia-CoA via a phenyl-CoA thioester 
synthon. 
2.4 Conclusion 
This review of literature methods whereby CoA is currently prepared showed that 
these methods can be divided in two basic categories. The first group consists of 
methods which are purely based on chemical synthetic methods and transformations, 
while the second also uses enzymatic transformations to prepare the CoA 
analogues. We identified the major drawbacks of the synthetic strategy and showed 
how the chemo-enzymatic based strategies have developed to address these 
drawbacks. 
The current best-practice chemo-enzymatic method is based on a one-pot reaction 
using SaCoaA, EcCoaD and EcCoaE to transform pantetheine analogues to their 
related CoA analogues. However, this methodology still has a major drawback in 
that it is solution-based, causing large amounts of protein to be destroyed during 
work-up of the product. This makes the method very expensive and thus not suitable 
for large scale synthesis. This drawback may be addressed by immobilization of the 
enzymes on a solid support, and subsequent construction of a multi-enzyme reactor 
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to prepare the CoA analogue. Not only would this allow the enzymes to be reused, 
but may also significantly improve the separation and purification of the product. 
In the next chapter we will introduce the concept of protein immobilization and 
discuss the construction, expression and purification of six novel fusion proteins 
aimed at achieving this goal. 
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Chapter 3 
Expression and Purification of CoA Biosynthetic Enzymes 
as Novel CBD-fusion Proteins 
3.1 Introduction 
In a previous study from our laboratory we have looked at the construction of fusion 
proteins to achieve the immobilization of CoA biosynthetic enzymes on a solid 
support. Cellulose was identified as an ideal supporting material for enzyme 
immobilization since it is inexpensive, biodegradable and approved for use in most 
pharmaceutical products (1, 2). Cellulose binding domains (CBDs) were identified as 
a means whereby immobilization on cellulose could be obtained. 
CBDs are carbohydrate binding modules found in cellulases. The primary function of 
these domains is to bind the cellulases to cellulose. There are more than 150 known 
CBD sequences, which have been divided into 13 families based on sequence 
similarity (3). 
In the previously mentioned study several· attempts were made at the construction of 
fusion proteins of different CBD domains with the CoA biosynthetic enzymes from E. 
coli. One of the major struggles that we encountered with this work was that the 
CBD-fusions were often only insolubly expressed, a result which was in agreement 
with the observation that CBDs tend to form inclusion bodies during expression. 
Finally a CBD was identified that does not promote inclusion body formation and 
whose fusions are often found to be soluble (4). This CBD, CBDcipA is a cellulose 
binding domain from Clostridium thermocel/um and forms part of the third family of 
CB Os. 
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A vector encoding for the expression of CBDcipA with a proline-threonine enriched 
linker (PT-linker) and an N-terminal 6 x Histidine tag was subsequently constructed, 
and used as base vector for the cloning of CoA biosynthetic enzymes as His-CBD-
fusion proteins. The first protein that was solubly expressed in this manner was the 
fusion construct CBDcipA-EcCoaD. 
In this chapter we describe how we built on this result by determining expression 
conditions for all three the CBD fusion proteins of the E. coli and S. aureus CoA 
biosynthetic enzymes that are currently employed in the preparation of CoA 
analogues. We also express the native counterparts of these proteins in order to 
compare their characteristics to those of the fusion proteins. 
3.2 Results and Discussion 
3.2.1 Construction of expression vectors 
Soluble expression of CBDEcCoaD has been reported in a previous study from our 
lab ( 5). We used this expression vector as a template for the construction of 
expression vectors for CBDEcCoaAE and CBDSaCoaADE. As shown in Figure 3.1 
this vector encodes for an N-terminal histidine tag on the CBD domain. This allows 
purification of the proteins using nickel based IMAC (6). 
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lac I 
RBS I NMl(107) 
, Initiation ATG 
6xHis-tag (N-tanninal) 
--Thrombin reeognltion site 
_-CBDc1pA 
~---~-- PT linker 
- Nder (782) 
pET28a-CBD-SaCoaA 
6714bp 
f1 origin 
ColE1 pBR322 origin / Kan(R) 
Figure 3.1: Newly constructed expression vector of pET28a-CBDc1pA-SaCoaA 
We also constructed expression vectors for the expression of native SaCoaDE with 
an N-terminal histidine tag, so that the same purification method could be used. The 
expression of the native EcCoaADE and SaCoaA proteins has been reported 
previously (7, 8). 
3.2.2 Expression trials 
Expression trials were conducted on all the newly constructed expression vectors. 
Various parameters were investigated to determine the optimal conditions for 
achieving soluble protein: 
• IPTG induction concentrations 
• Growth time after induction 
• Cell strains 
• Expression media 
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3.2.2.1 First attempt at expressing CBD-fusion proteins 
We first conducted small scale expression trials with CBDcipASaCoaA and 
CBDcipAEcCoaD fusion proteins. The plasmids were transformed into E. coli BL21 -
star(DE3) cells and induced with different IPTG concentrations. 
Expression trails were run at a constant temperature of 37°C and induced with IPTG 
concentrations varying between 50 µM and 1 mM. The growth time after induction 
was alternatively 3 hours or 18 hours (overnight). 
Soluble expression of both fusion proteins was achieved. The SOS-PAGE gel below 
shows the results of the various trials that were conducted with CBDcipASaCoaA (53 
kDa, Figure 3.2). The best expression for CBDcipASaCoaA was obtained with 
induction with 200 µM IPTG. For CBDcipAEcCoaD 250 µM IPTG gave the best 
results. Both these results are for expression trials that were conducted overnight. 
kDa 
225 _ 
150-
100 -
75 -
50 -
35 -
25 -
15 -
10 -
Crude extract of CBDCipA-SaCoaA 
Whole cell expression MW Cell free expression 
2 3 4 5 2 3 4 
- csosacoaA 
(53 kDa) 
Figure 3.2. Expression trials for pET-28a-CBDc;pA·SaCoaA with different IPTG concentrations 
at 37°C, overnight. Lane 1: 750 µM IPTG. Lane 2: 500 µM IPTG. Lane 3: 200 µM IPTG. Lane 4: 
100 µM IPTG. Lane 5: Molecular weight markers. Whole cell expression represents the expression of 
insoluble protein. Cell free expression represents the expression of soluble protein . 
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3.2.2.2 Expressing native S. aureus proteins 
Various strategies were investigated to achieve the expression of the native SaCoaD 
and SaCoaE. Expression conditions for SaCoaA were already available (8). 
In our first attempt we expressed the S. aureus proteins in E. coli BL21-star(DE3) 
cells using IPTG induction concentrations ranging between 50 µM and 1 mM. 
Expression was conducted at 37°C with growth times after induction being chosen as 
either three hours or 18 hours (overnight). The optimal expression conditions for 
SaCoaD and SaCoaE was determined as 50 µM IPTG and 100 µM IPTG grown 
overnight respectively. However, the poor yields compared to that achieved for the 
expression of the E. coli proteins urged us to investigate other methods as well 
(Table 3.1 ). 
We decided to use Tuner competent cells instead of E. coli BL21-star(DE3) to see if 
any improvement could be obtained.. Tuner cells are more sensitive to variation in 
IPTG concentrations than BL21-star(DE3). This is because these cells are 
dependent on passive diffusion of the IPTG into the cells whereas BL21-star(DE3) 
cells are dependent on an active transport system to carry IPTG across the cell wall. 
Transforming the plasmids into the Tuner cells proved somewhat problematic and no 
improvement in the expression of soluble protein was achieved. 
Previous reports have promoted auto-induction media as being simpler to work with 
and giving better expression yields than IPTG induction media (9). As stated by the 
name this media is auto-inducing, thus no IPTG is added after expression has 
started. It is also less sensitive to variation in growth time. 
We decided to attempt the use of ZYM-5052 a routine complex auto-inducing media. 
It is prepared in phosphate buffer, is versatile over a range op conditions and 
provides high density cultures. The SaCoaDE plasmids were therefore once again· 
transformed into E. coli BL21-star(DE3) and incubated overnight in the auto-inducing 
media. This produced much better expression levels {Table 3.1 ). 
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3.2.2.3 Second attempt at expressing CBD-fusion proteins 
Since expression with auto-induction media proved so successful we decided to 
express all the fusion proteins in auto-induction media and compare the results to 
that achieved by IPTG induction. 
A summary of the results obtained from the two expression methods are presented in 
Table 3.1. From this it was very clear that auto-induction is the more efficient method 
of expression. In all instances better yields were obtained than when IPTG inducing 
media was used. 
Proteins 
EcCoaA 
EcCoaD 
EcCoaE 
SaCoaA 
SaCoaA 
SaCoaD 
SaCoaE 
CBDSaCoaA 
CBDSaCoaD 
CBDSaCoaE 
CBDEcCoaA 
CBDEcCoaD 
CBDEcCoaE 
IPTG induction Auto-Induction media 
mg/L (IPTG concentration) 
59.4 (800 µM) 
51.8 (1 mM) 
58.0 (1 mM) 
19.4 (500 µM) 
3 hours at 37°C 
overnight at 37°C 
2.9 (50 µM) 
3.2 (100 µM) 
2.4 (200 µM) 
1.8 (250 µM) 
mg/L 
20.4 
12.3 
14.8 
4.1 
8.8 
17.6 
45.4 
9.2 
28.6 
Table 3.1: Summary of the expression conditions and over-expression yields for all 
EcCoaADE, SaCoaADE, CBDEcCoaADE and CBDSaCoaADE proteins. 
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3.2.3 Purification of native and newly constructed fusion proteins 
After successful expression of the six fusion proteins and their native counterparts we 
had to develop a purification strategy. As was mentioned previously all the proteins 
were expressed with an N-terminal 6 x His-tag, allowing their purification using nickel-
based IMAC. In our first attempt at purification, using this protocol, we used a Tris-
HCI (pH 7.6) buffer system which caused precipitation of the proteins. To resolve this 
matter we tested different buffer systems at various pH values and concentrations. 
Tris-HCI (10 mM, pH 7.6 and pH 8.0), HEPES (20 mM, pH 8.0), phosphate buffer (10 
mM, pH 8.0 and pH 7.4) and phosphate buffer (20 mM, pH 7.2) were tested. We left 
the enzyme in the buffer solution at 4°C overnight. Most of the enzyme precipitated 
out of the Tris-HCI and HEPES buffer solutions, while the enzymes in the phosphate 
buffers (10 mM) stayed perfectly soluble. For our second attempt at protein 
purification we used the 10 mM phosphate buffer (pH 7.4). This time no precipitation 
occurred and pure protein solutions were obtained for the native E. coli and S. 
aureus proteins (Figure 3.3). 
In spite of this success there was one consistent peptide band visible in all the 
purified CBD-fusion protein extracts. To improve the purification of our target 
proteins we tried to elute the protein using an imidazole gradient and various 
imidazole concentrations, but still failed to remove the unknown peptide band from 
any of the solutions. We therefore decided to first determine whether the purified 
protein - containing the single major contaminant - showed any activity before 
attempting to optimize the purification protocol. 
For the activity assays we estimated the purity of the fusion protein stocks by 
analysis of SOS-PAGE gels used to separate the target protein from the 
contaminant. We used a computer program, UN-SCAN-IT gel 6. 1, to determine the 
densities of each band, from which the overall purity could be determined. The 
percentage purities of the E. coli CBD-fusion proteins were found to be: CoaA 89.8%, 
CoaD 68.8%, and CoaE 91.7%. For the S. aureus CBD-fusion proteins the 
43 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 3 - Expression and Purification of Novel CBD-fusion Proteins 
percentage purities were determined as CoaA 57.8%, CoaD 78.4% and CoaE 73.9% 
(Figure 3.3). 
Unidentified peptide---. 
Unidentified peptide ---
Purified native and fusion proteins of E.coli 
3 2 MW 6 5 4 MW kDa 
------
'------y------- '------y-------
Fusion proteins Native proteins 
Purified native and fusion proteins of S. aureus 
MW 3 2 MW 6 5 4 
'------y------- '------y-------
Fusion proteins Native proteins 
150 
_100 
-75 
-50 
--35 
-25 
kDa 
_225 
-150 
-100 
-75 
-50 
-35 
-25 
Figure 3.3: E. coli native and fusion proteins after purification (top): Lane 1: CBDEcCoaA (61 
kDa, 90 % pure). Lane 2: CBDEcCoaD (42 kDa, 69 % pure) . Lane 3: CBDEcCoaE (47 kDa, 92 % 
pure). Lane 4: EcCoaA (39 kDa). Lane 5: EcCoaD (20 kDa). Lane 6: EcCoaE (25 kDa). S. aureus 
native and fusion proteins after purification {bottom): Lane 1: CBDSaCoaA (53 kDa, 58 % pure). 
Lane 2: CBDSaCoaD (43 kDa, 78 % pure) . Lane 3: CBDSaCoaE (48 kDa, 74 % pure) . Lane 4: 
SaCoaA (32 kDa). Lane 5: SaCoaD (21 kDa). Lane 6: SaCoaE (25 kDa). 
The unknown peptide band must either be an N-terminal fragment of the fusion 
proteins, or another His-tag containing protein that is co-expressed with the fusion 
constructs. From the SOS-PAGE gels in figure 3.3 we can see that the unknown 
peptide band is about 25 kDa in size. This strongly suggests that cleavage occurs 
somewhere between the PT-linker and the protein itself, since the size of the 
cellulose binding domain plus the 6 x His-tag and the PT-linker is estimated to be 
27.23 kDa. 
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3.2.4 Confirming the retained activity of the modified proteins 
After the successful expression and purification of the CBD-fusion constructs and the 
native S. aureus proteins we had to determine if the modified enzymes had retained 
their activity. We chose N-pentylpantothenamide as the substrate to verify the 
activity of the various enzymes. This is a substrate known to be active with the native 
E. coli enzymes and since it does not have a thiol group the interference of disulfide 
forming side-reactions was eliminated. 
Set 1: SaCoaADE 
Set 2: CBD-EcCoaADE 
Set 3: CBD-SaCoaADE 
Reaction 1 
HO~~~~~ __,,_C=oa'"'-A--1,_._ 
0 0 
H H 
N~N~ 
Reaction 2 
0 0 
4'-phospho-N-pentylpantothenamide 
Mr= 368.36 
Analysis : 
-----MS 
~H CoaAD 
HO'"~~~~~ 
Analysis : 
-----MS 
HPLC 
0 0 
Reaction 3 
~H CoaADE 
HO'"~~~~~ 
0 0 
Dephospho-Ethyldeth1aCoA 
Mr=699-56 
NH2 
N:CN ::t~ .J 
,?(~~~~ 
0 0 
EthyldethiaCoA 
Mr= 779.56 
Analysis: 
MS 
HPLC 
Figure 3.4: Confirming the retaining of activity by the modified CoA biosynthetic enzymes. 
Three sets of reactions were conducted, each consisting of the three presented reactions. N-
pentylpantothenamide was the chosen substrate for all the reactions. 
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To determine the activities of all the newly purified proteins three sets of reactions 
were conducted (Figure 3.4). Each reaction contained 0.5 mM N-pentylpantothen-
amide and 15 µg of the required enzyme(s) in a 150 µI reaction. The reactions were 
incubated for 20 minutes at 37°C and then analyzed by HPLC and LC-MS. The first 
set of reactions was used to determine the activity of all three the native S. aureus 
enzymes. The second set was used to determine the activity of all three the E. coli 
CBD-fusion proteins and the third set was used to determine the activity of all three 
the S. aureus CBD-fusion proteins. Each set consisted of three reactions. The first 
reaction in every set contained only the CoaA enzyme, thus formation of 4'-phospho-
N-pentylpantothenamide was assayed. The second reaction contained both the 
CoaAD enzymes, thus formation of dephospho-ethyldethia-CoA was assayed. The 
third reaction contained all three the biosynthetic enzymes and thus formation of the 
CoA analogue, ethyldethia-CoA, was assayed. 
HPLC and LC-MS analyses confirmed that all the enzymes do retain activity after 
being fused with the cellulose binding domain (Figure 3.5). The HPLC spectra were 
measured at 220 nm and 254 nm, although only the 254 nm spectra are shown. 4'-
Phosphopantetheine is not visible at 254 nm and absorbs very weakly at 220 nm 
therefore its spectra is not shown, but the transformation was still confirmed by ESl-
MS. The results of the ESl-MS analyses in. the ES- mode are presented below.· 
This assay has proved that we have succeeded in constructing biosynthetic enzymes 
fused to a CBD domain without compromising the activities of the enzymes. We also 
proved that substrate promiscuity of the CoaA enzymes is retained. These results 
prove that we should be able to use these enzymes in the construction of a 
bioreactor for the synthesis of CoA analogues. 
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Figure 3.5: LC-MS and HPLC analyses of the three biosynthetic reactions confirming formation 
of both intermediates and the final CoA analogue. Reaction 1: Assay containing only CoaA. 
Reaction 2: Assay containing CoaAD. Reaction 3: Assay containing CoaADE. 
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3.3 Conclusion 
We have successfully constructed, over-expressed and purified six new fusion 
proteins, CBDSaCoaADE and CBDEcCoaADE in good yields. We have also 
determined optimal expression conditions for SaCoaADE. Total purification of the 
native S. aureus and E. coli enzymes was achieved, while the CBD-fusion proteins 
were only partially purified as a single major contaminant, thought to be the unfused 
CBD module, could not be separated from the target protein. After this partial 
purification we determined the percentage purity of the fusion proteins. Most 
importantly we have shown that the CBD-fusion proteins have retained their activity 
and that they could thus be used in the preparation of CoA and its analogues. 
In the next chapter we discuss the characterization of these enzymes and we 
determine how immobilization on cellulose may affect their activity. 
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3.4 Experimental procedures 
3.4.1 Materials and Methods 
All the expression vectors and competent cell strains were purchased from Novagen. 
The primers were synthesized by lnqaba Biotechnology (Pretoria, South Africa) and 
sequencing of the plasmids was done by automated DNA sequencing also at lnqaba 
Biotechnology (Pretoria, South Africa). 
All the purification columns were purchased from Amersham Biosciences. The 
HiTrap™ Chelating Columns are from Amersham Biosciences. Protein purification 
was conducted on an AKTAprime purification system also from Amersham 
Biosciences. The software used for scanning the protein gels, UN-SCAN-IT gel 6.1, 
was purchased from Silk Scientific. The Quick Start Bradford Protein Assay Kit was 
purchased· from Bio-rad. It contained the Bradford reagent and the Bovine Serum 
Albumin standard set. 
All the chemicals used were purchased from Aldrich or Sigma and is of the highest 
quality. 
A high performance liquid chromatography (HPLC) instrument (Agilent 1100 series) 
was used for the analysis of the biosynthetic reactions. Analyses were done on a 
Gemini Su C18 column (30x2.00 mm) purchased from Phenomenex. A Heraeus 
Multifuge® 3S/3S-R was used for all the large scale centrifugation. The smaller 
scale centrifugation was conducted on a Heraeus Biofuge pico centrifuge. All 
absorptions were measured using a Varioscan multiplate spectrophotometer from 
Thermo Labsystems. 
3.4.2 Expression trials 
All the plasmids were cloned and expression vectors constructed by Mrs. L. A. Brand 
prior to the investigation. 
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3.4.2.1 IPTG induction 
The plasmids pET28a-CBOcipAEcCoaO and pET28a-CBOcipASaCoaA were 
transformed into BL21 star(OE3). Starting cultures (5 ml) of each were prepared in 
LB broth supplemented with kanamycin sulphate (30 mg/I) and grown overnight (18 
hours). Liquid media cultures, 15 ml LB broth supplemented with kanamycin 
sulphate (30 mg/I), were induced with 100 µI of the starting cultures and grown at 
37°C till an 00600 -0.6 was reached. The liquid media cultures were induced with a 
range of IPTG concentrations and grown for varying times at 37°C to determine the 
optimum expression conditions. The cells were harvested at 4500 x g for 20 minutes 
and whole cell and cell free expression were determined. 
The procedure was repeated with the plasmids pET28a-SaCoaO and pET28a-
SaCoaE transformed into BL21star(OE3) and Tuner cells. 
3. 4. 2. 2 Whole cell analysis 
The harvested. cells were re-suspended in 2 ml Tris-HCI (10 mM, pH 8) and 200 µI of 
the cell suspension was transferred to a 1.5 ml Eppendorf tube and centrifuged at 
13 000 rpm for 2 minutes. The supernatant was discarded and the pe,llet re-
suspended in 50 µI Tris-HCI (10 mM, pH 8). An equal amount of SOS-PAGE loading 
buffer was added to the tube and the suspension was boiled for 5 minutes at 95°C. 
The suspension was spun down before being loaded onto a 12% SOS-PAGE gel that 
was stained with Coomassie Brilliant Blue R-250. 
3.4.2.3 Cell free analysis 
The harvested cells were re-suspended in 2 ml Tris-HCI (10 mM, pH 8) and 200 µI of 
the cell suspension was transferred to a 1.5 ml Eppendorf tube and centrifuged at 
13 000 rpm for 2 minutes. The supernatant was discarded and the pellet re-
suspended in 50 µI Tris-HCI (10 mM, pH 8). Half a volume of glass beads was 
added and the suspension was vortexed for 10 minutes to disrupt the cells. SOS-
PAGE loading buffer (50 µI) was added to the tube and the suspension was boiled for 
5 minutes at 95°C. Afterwards it was spun down before being loaded onto a 12% 
SOS-PAGE gel that was stained with Coomassie Brilliant Blue R-250. 
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3.4.3 Overexpression of E. coli biosynthetic enzymes 
Overexpression of EcCoaADE was conducted at 37°C in 500 ml LB broth 
supplemented with 30 mg/I of kanamycin sulphate. The cells were grown up to 
00600 -0.6, before being induced with different concentrations of IPTG and then left 
to grow overnight at the same temperature. EcCoaA were induced with 800 µM 
IPTG, and EcCoaDE with 1000 µM IPTG. 
3.4.4 Overexpression of native S. aureus and CBD-fusion proteins 
3.4.4. 1 IPTG induction 
SaCoaDE, CBDEcCoaD and· CBDSaCoaA were overexpressed according to the 
optimal conditions determined in the expression trials. All the overexpresssions were 
conducted at 37°C in 500 ml LB broth supplemented with 30 mg/I kanamycin 
sulphate. The cells were grown up to ODeoo -0.6, before being induced with IPTG 
and then left to grow overnight at the same temperature. SaCoaD was in induced 
with 50 µM, SaCoaE with 100 µM, CBDEcCoaD with 200 µMand CBDSaCoaA with 
250 µM. 
3.4.4.2 Auto-induction media (ZYM-5052) 
A complex auto-induction media (ZYM-5052) was used for the overexpression of 
SaCoaADE, CBDEcCoaADE and CBDSaCoaADE. All the plasmids were 
' 
transformed into E. coli BL21-star(DE3) and overexpressed at 37°C, overnight. The 
cells were harvested at 4500 x g for 30 minutes and stored at -80°C till used again. 
3.4.5 Protein purification 
The harvested cells were re-suspended in sonication buffer (20 mM phosphate 
buffer, 500 mM NaCl, pH 7.4) and disrupted by sonication in 6 x 60 second cycles. It 
was centrifuged at 15 000 x g for 30 minutes to pellet the cell debris. The collected 
crude extract was purified on a 1 ml His Trap TM chelating column pre-loaded with 
NiS04 (100 mM) using an AKTAprime purification system. Weakly bound proteins 
were removed by washing with sonication buffer and sonication buffer containing 75 
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mM imidazole, successively. The protein of interest was eluted by increasing the 
imidazole concentration to 500 mM. Elution of the protein was monitored at A280. 
After purification the protein was loaded onto a HiTrap TM desalting column and 
washed with gel filtration buffer (25 mM phosphate buffer, 5 mM MgCl2, pH 7.4) 
before adding 5% glycerol and storing it at -80°C. 
Purity of the native enzymes was confirmed by running a 12% SDS-PAGE gel. 
SDS-PAGE gels of the fusion proteins were electronically analyzed using gel 
digitizing software. The gels were scanned in on the computer and the software was 
used to determine the ratio between the known and the consistent unidentified 
protein band. 
3.4.6 Determining enzyme concentrations 
Enzyme concentrations were determined using the Quick Start Bradford protein 
assay. In this assay Coomassie Brilliant Blue R-250 dye binds to the enzymes to 
convert it to a stable unprotonated blue form, which can be detected at 595 nm. 
Bovine Serum Albumin was used as the standard. It has a linear range of 125-1000 
µg.mr1. 5 µI of each concentration and of different dilutions of the protein was 
transferred to a mictrotitre plate. Bradford reagent (250 µI) was added to each well. 
Distilled water was used as a blank. The plate was incubated at room temperature 
for 5 minutes after addition of the Bradford reagent. All the measurements were 
done in triplicate. The Beer-Lambert law was used to convert the measurements to 
concentrations. 
3.4.7 Activity of native S. aureus and CBC-fusion proteins 
3.4. 7. 1 Biosynthesis of ethy/dethia-CoA 
Each reaction mixture contained 50 mM Tris-HCI buffer (pH 7.6), 5 mM ATP, 5 mM 
MgCl2, 2 mM DTT and 15 µg of the required enzyme in a final reaction volume of 150 
µI. The reactions were initiated by addition of 0.5 mM of N-pentylpantothenamide 
and incubated for 20 minutes at 37°C. Three reactions were conducted to confirm 
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the formation of the intermediates in the pathway. The first reaction contained only 
CoaA, the second contained both CoaA and CoaD and the third contained CoaADE. 
The reactions were quenched by transferring the tubes to 95°C for 5 minutes which 
caused precipitation of the proteins. The precipitated protein was collected by 
centrifugation for 5 minutes at 13 000 rpm before the supernatant ( 15 µI) could be 
injected onto the HPLC column for analysis. 
3.4. 7.2 Conditions for HPLC analysis 
The analysis method took 15 minutes with a flow rate of 1 ml/min. The method 
started with 95% of a 100 mM NH40Ac buffer solution (pH 6.6) and 5% acetonitrile. 
The acetonitrile concentration increased as the method developed: 5-40% MeCN, 1-
3 minutes; isocratic, 3-8 minutes; 40-80% MeCN, 8-10 minutes; isocratic, 10-14 
minutes; 80-5%, 14-15 minutes; 5% for 5 minutes before the next injection. 
Absorption was monitored at 254 .nm. The measured retention times were: ATP, 0.1 
min, 3'-dephospho-ethyldethia-CoA, 2.6 min and ethyldethia-CoA, 0.7 min. LC-MS of 
the reactions were also conducted which allowed the detection of 4'-phospho-N-
pentylpantothenamide. 
3.4. 7.3 Conditions for LC-MS analysis 
LC-MS analysis was performed on a Waters 2690 Separations Module with a Waters 
996 Photodiode Array Detector, followed by MS analysis on a Waters Quattro 
Micromass mass spectrometer. 
For LC separation the column was equilibrated with 95% of a 100 mM NH40Ac buffer 
solution (pH 6.6) and 5% acetonitrile over the first 3 minutes of the analysis. The 
acetonitrile concentration increased as the method developed: 5-40% MeCN, 3-6 
minutes; isocratic, 6-10 minutes; 40-60% MeCN, 10-11 minutes; isocratic, 11-15 
minutes; 60-80%, 15-16 minutes; isocratic, 16-18 minutes; 5% up to 25 minutes. A 
flow rate of 1 ml/min was maintained. The products were detected at A220 or A2s4 
depending on the absorbance properties of the compounds. Peak identification was 
done by analysis of the average mass spectrum (negative mode) of each peak. 
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Chapter 4 
Characterization of the Newly Constructed CoA 
Biosynthetic Fusion Proteins 
4.1 Introduction 
We are aiming to build a reactor for the biosynthesis of CoA analogues. In order to 
achieve this we need to know certain characteristics of the fusion proteins that will 
form the core of this reactor. In this chapter we focus on the determination of these 
characteristics. 
In chapter three we reported the construction of six novel fusion proteins originating 
from two sources, namely E. coli and S. aureus. Thus we have duplicates of each of 
the biosynthetic enzyme that are needed to produce CoA analogues. This gives us 
eight possible enzyme combinations that might produce CoA analogues from 
pantothenamide substrates. 
The first objective of the work discussed in this chapter was to identify the best 
combinations from these eight possibilities for use in the construction of a reactor. 
Subsequently kinetic parameters had to be determined for the fusion proteins making 
up these combinations to facilitate the future design and construction of bioreactors. 
Finally we determined the influence of modification and immobilization of the activity 
of the fusion proteins by comparison to the activity of the native enzymes. 
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4.2 Results and Discussion 
4.2.1 Comparing the activity of the different fusion protein combinations 
In order to compare the activities of all the possible fusion proteins combinations we 
reconstituted the CoA biosynthetic pathway using a CoaA, a CoaD and a CoaE 
enzyme from either E. coli or S. aureus in all possible combinations. The activities of 
these combinations were determined by analysis of the reaction mixtures by HPLC. 
An internal standard (guanosine) was co-injected with all these analyses to allow us 
to compare the yields of the various reactions. Each 150 µI reaction contained 15 µg 
of each of three fusion proteins and 0.5 mM substrate. The reactions were incubated 
for 60 minutes at 37°C before analysis was done. 
Two substrates were chosen for these reactions namely, pantetheine and N-
pentylpantothenamide. Pantetheine, although not the natural substrate of the CoA 
biosynthetic pathway, is an advanced intermediate which can be used by the 
CoaADE enzymes in a salvage manner. N-pentylpantothenamide was used in the 
previous chapter (Figure 4.1 ). 
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Figure 4.1: Reactions used to compare the activity of the different fusion protein 
combinations. Each reaction contained a CoaA, CoaD and a CoaE enzyme from either E. coli or S. 
aureus. 
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4. 2. 1. 1 Comparing E. coli to S. aureus 
The first set of reactions was constructed to compare the activities of the enzymes 
from the two sources, namely E. coli and S. aureus. Thus four reactions were 
conducted, each containing only E. coli or S. aureus enzymes with either one of the 
mentioned substrates. All four of these reactions were conducted in triplicate. 
In Figure 4.2 we present the average yields of the four reactions as ratios with the 
internal standard. C1 represents the E. coli proteins and C2 represents the S. 
aureus proteins. From these results we can conclude that both substrates are 
formed in higher yields by the E. coli enzymes. 
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Figure 4.2: Comparing the activities of the CBD-fusion proteins from E. coli (C1) and S. aureus 
(C2). CoA was biosynthesized from pantetheine (pink). Ethyldethia-CoA was biosynthesized from N-
pentylpantothenamide (green). Each of the values represents the average yield of three identical 
reactions as a ratio to the internal standard, guanosine. The error bars indicate the standard 
deviations of the average values. 
Our results also show that for C1 ethyldethia-CoA, the product formed from N-
pentylpantothenamide, is produced in higher yields than CoA from pantetheine. This 
is in agreement with previous studies of the native enzymes and serves as 
confirmation of the validity of our assay ( 1). 
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4.2.1.2 Comparing combinations containing SaCoaA 
Since EcCoaA is feedback inhibited, while SaCoaA is not, we wanted to see if there 
is an enzyme combination containing SaCoaA that would show better activity than 
the combination using only the E. coli enzymes. There are three possible enzyme 
combinations containing CBDSaCoaA (excluding C2, which was tested in the 
previous experiment): 
• CBDSaCoaAD and CBDEcCoaE (C3) 
• CBDSaCoaA and CBDEcCoaDE (C4) 
• CBDSaCoaA, CBDEcCoaD and CBDSaCoaE (CS) 
We compared the activities of these combinations using the same two substrates as 
before. The results are presented in Figure 4.3. 
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Figure 4.3: Comparing the activities of the three CBD-fusion protein combinations that include 
CBDSaCoaA. Three enzyme combinations were assayed : CBDSaCoaAD and CBDEcCoaE (C3), 
CBDSaCoaA and CBDEcCoaDE (C4), CBDSaCoaA, CBDEcCoaD and CBDSaCoaE (CS). CoA was 
biosynthesized from pantetheine (pink). Ethyldethia-CoA was biosynthesized from N-
pentylpantothenamide (green). Each of the values represents the average yield of three identical 
reactions as a ratio with the internal standard, guanosine. The error bars indicate the standard 
deviations of the average values. 
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From these results we can conclude that C3 is the least preferred of the three 
combinations. This implies that CBDSaCoaA and CBDEcCoaD is a better 
combination than CBDSaCoaAD. There is very little difference between the activities 
of C4 and CS indicating that there is not much difference in the activity of the two 
CoaE enzymes. 
4.2.1.3 Comparing combinations containing EcCoaA 
Next we compared the activities of the possible fusion protein combinations 
containing CBDEcCoaA, excluding C1 which has already been discussed: 
• CBDEcCoaAD and CBDSaCoaE (C6) 
• CBDEcCoaA and CBDSaCoaDE (C7) 
• CBDEcCoaA, CBDSaCoaD and CBDEcCoaE (CB) 
Using the same substrates as before the following results were obtained (Figure 4.4): 
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Figure 4.4: Comparing the activity of the three CBD-fusion protein combinations that include 
CBDEcCoaA. Three enzyme combinations were assayed : CBDEcCoaAD and CBDSaCoaE (C6), 
CBDEcCoaA and CBDSaCoaDE (C7), CBDEcCoaA, CBDSaCoaD and CBDEcCoaE (CB). CoA was 
biosynthesized from pantetheine (pink) . Ethyldethia-CoA was biosynthesized from N-
pentylpantothenamide (green). Each of the values represents the average yield of three identical 
reactions as a ratio with the internal standard , guanosine. The error bars indicate the standard 
deviations of the average values. 
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C6 was the only combination that showed significant activity. C7 and CS containing 
CBDEcCoaA and CBDSaCoaD showed no activity with pantetheine and negligible 
activity with N-pentylpantothenamide. 
4.2.1.4 Identifying the preferred enzyme combinations 
Using our results from the activity assays we could now identify the two preferred 
combinations, one each for the biosynthesis of either CoA or ethyldethia-CoA. These 
two combinations could then be further characterized for use in the construction of a 
reactor. Since combinations C7 and CS showed no significant activity with either of 
the substrates we had six combinations to consider. 
In considering the biosynthesis of CoA from pantetheine we identified three possible 
combinations - C4, CS and C6 - based on their reaction yields. To choose between 
these we considered the expression yields and % purity of the various proteins. 
In C6 we used CBDEcCoaA while the S. aureus enzyme was used in both C4 and 
CS. CBDEcCoaA expresses with an average yield of 45.4 mg/I whereas 
CBDSaCoaA expresses with an average yield of only 4.1 mg/I (Table 3.1 ). 
Furthermore, CBDEcCoaA can be obtained in 90% purity, but CBDSaCoaA is only 
58% pure (Figure 3.3). This suggests that combination C6, made up of 
CBDEcCoaA, CBDEcCoaD and CBDSaCoaE is the combination of choice for the 
preparation of CoA. However, a potential' problem with this choice is that 
CBDEcCoaA is used· in this combination, an enzyme that experiences feedback 
inhibition. Nonetheless, we decided on using C6 in our further studies since the 
problem of feedback inhibition could still be addressed in the manner in which the 
bioreactor would be constructed. 
In considering the biosynthesis of ethyldethia-CoA we identified four possible 
combinations - C1, C4, CS and C6 - based on their reaction yields. Again we 
considered the expression yields and % percentage purity of the respective proteins 
to make a selection from among these combinations. 
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Using the same argument that takes the expression yields of the proteins in question 
into account we decided to eliminate C4 and CS, which involves using CBDSaCoaA 
which expresses at low yields and with major impurities. This leaves C1 and C6, 
which only differs in the source of the CoaE enzyme. Comparing the expression 
yields and % purity of CBDSaCoaE and CBDEcCoaE we find that CBDEcCoaE can 
be obtained in 92% purity with an expression yield of 28.6 mg/I. On the other hand 
CBDSaCoaE can only be obtained in 74% purity with an expression yield of 17.6 
mg/I. We thus decided that C1 will be used for the biosynthesis of ethyldethia-CoA in 
our further studies. 
To conclude we have identified the two preferred enzyme combinations for the 
biosynthesis of CoA and· ethyldethia-CoA to be used in our further studies as C6 and 
C1 respectively. 
4.2.2 Determining kinetic parameters of the selected proteins 
Next we wanted to determine the kinetic parameters of the four fusion proteins and 
their native counterparts as are represented by C6 and C1, which would require the 
availability of pure fusion protein stocks. Up to date we have only managed to 
determine the percentage purity of the fusion proteins with the putative N-terminal 
fragment as contaminant (Figure 3.3). Thus we first had to optimize our purification 
strategy. 
4.2.2. 1 Further purification of fusion protein constructs 
Anion exchange columns have previously been implemented for the purification of 
CBD-fusion proteins (2-4). In these protocols the crude extract is loaded onto a 
MONO Q or DEAE column that is pre-equilibrated with phosphate buffer, followed by 
elution of the protein with a salt gradient. In order to optimize our purification strategy 
we set out to use an anion exchange column, 16/10 DEAE FF column, and 
succeeded in successfully separating the unknown peptide from the partially purified 
CBDEcCoaDE and CBDSaCoaE enzyme solution (Figure 4.5). 
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Figure 4.5: Enzyme purification with a DEAE anion exchange column showing separation of 
the unknown peptide band and CBDEcCoaD. The blue line represents the proteins absorption and 
the green line represents the NaCl gradient. 
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Figure 4.6: SOS-PAGE gel of the fusion proteins after purification on an anion exchange 
column . Lane 1: CBDEcCoaA (after purification). Lane 2: CBDEcCoaA (before purification). Lane 
3: CBDEcCoaD (after purification) . Lane 4: CBDEcCoaD (before purification). Lane 5: CBDEcCoaE 
(after purification) . Lane 6: CBDEcCoaE (before purification). Lane 7: Molecular weight markers. 
Lane 8: CBDSaCoaE (after purification). Lane 9: CBDSaCoaE (before purification). 
Unfortunately the same strategy failed to purify CBDEcCoaA (Figure 4.6). Instead 
we found that the solution was less pure after this procedure, indicating that 
degradation possibly occurs during purification. We therefore decided to rather use 
the 90% pure stock that was obtained after the first purification for the kinetic studies. 
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4.2.2.2 Kinetic parameters of the CoaA enzymes 
The assay that we used measures the decrease in NADH concentration in a coupled 
reaction (Scheme 4.1) and is a well-established assay of kinase enzymes. 
Pantetheine 
OH H H HO~N~N~SH 
0 0 
Pyruvate 
Lactate 
dehydrogenase 
Lactate 
4'-Phosphopantetheine 
CoaA 
Phosphoenolpyruvate 
Pyruvate kinase 
NADH 
NAD+ ~ measure decrease of NADH @ 340nm 
Scheme 4.1: The assay used to determine the kinetic parameters of EcCoaA, CBDEcCoaA, 
EcCoaE, CBDEcCoaE, SaCoaE and CBDSaCoaE. 
Using this assay, kinetic parameters of EcCoaA and CBDEcCoaA were determined 
for pantetheine and N-pentylpantothenamide by fitting the data to the Michaelis-
Menten equation (Figure 4.7). These kinetic results show that the addition of the CBD 
fusion does not negatively impact on the activity of the CBDEcCoaA enzymes; in 
fact, they have higher specificity constants for both substrates compared to the native 
enzymes. 
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Figure 4.7: Activity of EcCoaA and CBDEcCoaA with pantetheine and N-pentyl-
pantothenamide. Initial rate plots of EcCoaA (•)and CBDEcCoaA (0) against increasing substrate 
concentrations. Substrates used: N-pentylpantothenamide (left) and pantetheine (right}. Curves 
show fits of the individual data sets to the Michaelis-Menten equation. 
4.2.2.3 Kinetic parameters of the CoaD enzymes 
The activity of the CoaD enzymes was assayed. using an assay which couples the 
production of pyrophosphate (which is released during transfer of the adenylyl group 
to phosphopantetheine) to the consumption of NADH, as shown in Scheme 4.2. The 
pyrophosphate is used in a three step enzymatic synthesis to yield dihydroxyacetone 
phosphate (DHAP). Two moles of DHAP consumes two moles of NADH to yield one 
mole of 2-glycerol-3-phosphate. This implies that for every mole of 1.5 that is 
consumed two moles of NADH are also consumed. The decrease in the NADH 
concentration was measured at 340nm. 
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ATP PPi 
PPi + D-Fructose-6-phosphate 2 steps ,.. GAP 
TPI DHAP 
(+ DHAP) 
2DHAP + 2NADH + 2H+ GDH 2 glycerol-3-phosphate + 2 NAD+ 
Scheme 4.2: Determining the kinetic parameters of EcCoaD and CBDEcCoaD. Pyrophosphate 
(PPi) is transformed to D-glyceraldehyde-3-phosphate (GAP) and dihydroxyacetone phosphate 
(DHAP). GAP is transformed to DHAP. 2 moles DHAP utilize 2 moles NADH to form 2 moles 
glycerol-3-phosphate. The decrease in NADH concentration is measured at 340 nm. The two indicated 
enzymes are triosephosphate isomerase (TPI) and glycerophosphate dehydrogenase (GOH). 
The kinetic parameters of EcCoaD and CBDEcCoaD for the natural substrate 4' -
phosphopantetheine 1.5 were determined using this assay by fitting the data to the 
Michaelis-Menten equation (Figure 4.8). Again, the data show that the introduction of 
the CBD has a negligible effect on the activity of the enzyme. 
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Figure 4.8: Activity of EcCoaD and CBDEcCoaD with 4'-phosphopantetheine. Initial rate plots of 
EcCoaD (•)and CBDEcCoaD (0) against increasing substrate concentrations. 
4.2.2.4 Kinetic parameters of the CoaE enzymes 
For characterization of CoaE the same kinase assay as the one used to determine 
the kinetic parameters of EcCoaA was employed. CBDEcCoaE, SaCoaE and 
CBDSaCoaE were subsequently kinetically characterized using dephospho-CoA 1.6 
as substrate (Figure 4.9). The CBD fusions proteins again demonstrate slightly 
improved specificity constants. 
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EcCoaE 0.005 934.906 0.078 0.083 
CBDEcCoaE 0.018 5990.958 0.576 0.096 
SaCoaE 0.002 90.943 0.034 0.378 
CBDSaCoaE 0.002 102.009 0.058 0.564 
Figure 4.9: Activity of EcCoaE, CBDEcCoaE, SaCoaE and CBDSaCoaE with dephospho-CoA. 
Initial rate plots of E. coli CoaE (left) and S. aureus CoaE (right) against increasing. substrate 
concentrations. Curves show fits of the individual CoaE (•) and CBDCoaE (0) data sets to the 
Michaelis-Menten equation. 
4.2.3 Comparing the rate of biosynthesis between the native and the 
fusion proteins 
Before constructing the reactor we wanted to determine the effect of modification and 
of immobilization on- the activity of the identified CoA biosynthetic proteins. We thus 
needed to compare the activity of the two chosen combinations of biosynthetic 
enzymes in their different states as the native proteins and as CBD-fusion proteins -
the latter both in solution and immobilized on cellulose. 
We used the same HPLC assay that was developed for the comparison of the activity 
of the different enzyme combinations, except that the reaction's progress was 
monitored at smaller time intervals. 
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4.2.3.1 Native proteins vs CBD-fusion proteins in solution 
In the first assay we wanted to determine the effect of the CBD on the overall 
biosynthetic activity of the proteins. We thus compared the activity of the native 
CoaADE proteins to that of the CBD-fusion proteins over a set time period using 
either pantetheine or N-pentylpantothenamide as substrate (Figure 4.10). Enzyme 
combination C1 was used for the biosynthesis of ethyldethia-CoA from N-
pentylpantothenamide and enzyme combination C6 was used for the biosynthesis of 
CoA from pantetheine. 
pantetheine N-pentylpantothenamide 
700 100 
600 600 
~ 15()() 100% 
~ 
c 400 0 
:::I 
~ 300 c: 
~ 200 c 
0 
(,) 
100 100 
60 100 
Time (min) Time (min) 
• Native proteins 
o CBD-fusion proteins in solution 
Figure 4.10: Rate of biosynthesis for native and solution based CBD-fusion protein 
combinations. Enzyme combination C6 was used for the transformation of pantetheine to CoA (left). 
Enzyme combination C1 was used for the transformation of N-pentylpantothenamide to ethyldetia-
CoA (right). The data sets of the native (•) and the solution based CBD-fusion proteins (0) for the 
corresponding substrates were plot on the same graphs. Each data point represents an average of 
three values with the standard deviations indicated by the error bars. A 100% conversion equals 500 
µM. 
The results show that the rate of biosynthesis of CoA from pantetheine using the C6 
combination of enzymes is drastically increased by the CBD-fusion proteins 
compared to the native enzymes. While the native enzymes could only achieve a 
20% yield after 80 minutes the yield was increased to 100% after 60 minutes by the 
introduction of the CBD-domain. 
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For the biosynthesis of ethyldethia-CoA from N-pentylpantothenamide using the C1 
combination of enzymes very little difference between the rates of the native and the 
CBD-fusion proteins could be observed. After 20 min 80% conversion was achieved 
by both enzymes. 
4.2.3.2 CBD-fusion proteins in solution vs CBD-fusion proteins 
immobilized on cellulose 
In the second assay we wanted to determine the effect of immobilization on the 
activity of the proteins. However to be able to do this we first needed to immobilize 
the proteins on cellulose. Since we did not want to pointlessly waste protein during 
the immobilization procedure we set out to determine the binding curves of the 
various CBD-fusion proteins to cellulose. 
4.2.3.2.1 Immobilizing the fusion proteins 
To determine the binding capacity of the fusion-proteins to cellulose we added 
different masses of protein to a constant cellulose mass and determined the 
percentage immobilization in each case. A known amount of protein (100 µg, 150 
µg, 200 µg, 300 µg or 500 µg) was added to 10 mg of cellulose. These mixtures 
were subsequently incubated at room temperature for one hour to allow 
immobilization to take place. At the end of the hour the cellulose-bound protein was 
separated from the protein in solution by centrifugation. The amount of free protein 
present in the supernatant was determined by conducting a Bradford assay. This 
value was subtracted from the starting amount to determine the amount of protein 
that was successfully immobilized on the cellulose. Each of the immobilization 
reactions were conducted in triplicate. 
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Figure 4.11: Determining the % immobilization of the fusion proteins on cellulose. Different 
amounts of CBDEcCoaA (e), CBDEcCoaD (0), CBDEcCoaE (.6.) and CBDSaCoaE (T) was 
immobilized onto a constant cellulose mass. Each data point represents the average of three values 
with the error bars representing the standard deviations of these values. 
This data is presented as Figure 4.11. In this graph we have drawn a line through 
the point that represents a protein to cellulose ratio of 1: 1 i.e. when all the fusion 
protein added to the cellulose remained bound. The results show that this was only 
the case when protein was added in a ratio of 1 mg of protein to 100 mg of cellulose. 
We therefore decided to use this ratio in our further studies. 
4.2.3.2.2 Determining the effect of immobilization 
To compare the effect of immobilization on the overall rate of biosynthesis of the 
fusion proteins we used the same time-dependent HPLC assay that was developed 
to determine the effect of the CBD domain on the rate of biosynthesis of these 
proteins. The enzymes were immobilized on cellulose using the 1 mg protein to 100 
mg cellulose ratio determined above. Each of the enzymes was immobilized in a 
separate reaction before combining for the conduction of the biosynthesis reactions. 
The results from these biosynthesis reactions were compared to that of the CBD-
fusion proteins in solution previously shown in Figure 4.10 (Figure 4.12). 
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Figure 4.12: Rate of biosynthesis for solution based CBD-fusion protein combinations and 
immobilized CBD-fusion protein combinations. Enzyme combination CG was used for the 
biosynthesis of CoA from pantetheine (left). Enzyme combination C1 was used for the biosynthesis of 
ethyldethia-CoA from N-pentylpantothenamide (right). The data sets of the solution based CBD-fusion 
proteins ( 0) and the immobilized CBD-fusion proteins ( •) for the corresponding substrates were plot 
on the same graphs. A 100% conversion equals 500 µM. 
The result for the biosynthesis of CoA from pantetheine using enzyme combination 
C6 shows that by immobilizing the CBD-fusion proteins onto cellulose only an 80% 
yield of CoA is achieved after 80 min where with the solution based fusion proteins 
we previously achieved a 100% yield. Still it is 60% more than the yield of the native 
enzymes after the same period of time (Figure 4.10). 
For the biosynthesis of ethyldethia-CoA from N-pentylpantothenamide using enzyme 
combination C1 the results show an increase in the rate of the overall biosynthesis. 
While previously an 80% yield was achieved after 30 min this has now increased to 
100% by the introduction of the immobilized CBD-fusion proteins. 
For both the studied substrates we observed an increase in the overall reaction rates 
due to the modification and immobilization of the CoA biosynthetic fusion proteins on 
cellulose. This shows great promise for the implementation of these proteins in an 
immobilized reactor system. 
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4.3 Conclusion 
Eight possible CBD-fusion protein combinations were identified for the production of 
CoA and its analogues. Out of these we have chosen the two best possible 
combinations for the production of CoA and ethyldethia-CoA respectively. 
We characterized the four proteins that constitute these combinations by determining 
their kinetic parameters for their natural substrates and their binding capacities to 
cellulose. Furthermore, we determined the effect of modification and immobilization 
on the activities of the two combinations through comparative studies. 
From the comparative studies and the kinetic assays we could with great satisfaction 
deduce that no activity is lost through the introduction of the CBD domain or through 
the immobilization of the fusion proteins. Instead an increase in the overall reaction 
rates of the transformation reactions were observed when using the immobilized 
fusion proteins instead of the solution based native proteins. 
In the next chapter we will now use these positive results to guide us in the 
construction of a bioreactor for the production of various CoA analogues. 
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4.4 Experimental conditions 
4.4.1 Materials and Methods 
The Hi Prep TM 16/10 DEAE FF anion exchange column was purchased from 
Amersham Biosciences. Protein purification was conducted on an AKTAprime 
purification system. 
A high performance liquid chromatography (HPLC) instrument (Agilent 1100 series) 
was used for the analysis of the biosynthetic reactions. All the analyses were done 
with a Supelcosil™ LC-18-T 5 µm column (25 cm x 4.6 mm) with a Supelguard™ LC-
18-T guard column that was purchased from Sigma. A Hereaeus Multifuge® 3S/3S-
R was used for all the large scale centrifugation. The smaller scale centrifugation 
was conducted on a Heraeus Biofuge pico centrifuge. All absorption measurements 
a 
were conducted on a Varioscan multiplate spectrophotometer from Thermo 
Labsystems. 
All the chemicals used were purchased from Aldrich or Sigma and is of the highest 
quality. The fusion proteins were immobilized on Avicel PH-101 from Fluka. 
4.4.2 Comparative biosynthesis of CoA and ethyldethia CoA 
4. 4. 2. 1 Reaction conditions 
Each reaction mixture contained 50 mM Tris-HCI buffer (pH 7 .6), 5 mM ATP, 5 mM 
MgCl2, 2mM OTT and 15 µg of each required fusion enzyme in a final reaction 
volume of 150 µI. Reactions were initiated by addition of 0.5 mM of either N-
pentylpantothenamide or pantetheine and incubated for 60 minutes at 37°C. The 
reactions were quenched by transferring the tubes to 95°C for 5 minutes which 
caused precipitation of the proteins. The precipitated protein was collected by 
centrifugation for 5 minutes at 13 000 rpm before the supernatant could be injected 
onto the HPLC column for analysis. 
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4.4.2.2 Conditions for HPLC analysis 
Analyses were done with 25 µI of a sample containing 60 µI of the reaction mixture 
and 12 µI of a 6 mM guanosine solution (0.5 M HCI) as an internal standard. The 
analysis method took 20 minutes starting with 95% of a 100 mM phosphate buffer 
solution (pH 6.5) and 5% methanol. The methanol concentration increased from 5% 
to 30% between 3 and 10 minutes and then ran isocratic up to 20 minutes. There 
was a 5 minute post run to re-equilibrate the column before the next injection took 
place. Absorption was monitored at 254 nm. The retention times were: ATP, 3.6 
min; ADP, 3.8 min; AMP, 4.8 min; internal standard, 8.6 min; Coenzyme A, 9.3 min; 
Ethyldethia-CoA, 14.4 min. 
4.4.3 Purification of the fusion proteins 
Purification of the fusion proteins was conducted with a 16/10 DEAE FF column. The 
column was equilibrated with 50 ml of binding buffer (20 mM phosphate buffer, pH• 
7.4) before loading the protein. Then it was washed with another 20 ml of binding 
buffer and the protein was eluted with a gradient that ran over 200 ml, starting at a 
100% binding buffer and going up to 50% elution buffer (20 mM phosphate buffer, 1 
M NaCl, pH 7.4). Elution was monitored at A2ao. After purification the protein was 
loaded onto a HiTrap TM desalting column and washed with gel filtration buffer (25 mM 
phosphate buffer, 5 mM MgCb, pH 7.4) before adding 5% glycerol and storing it at 
-80°C. The purity of the fusion proteins was confirmed with an SOS-PAGE gel 
(12%). 
4.4.4 Kinetic assays 
4.4.4.1 EcCoaA and CBDEcCoaA 
Each assay contained 50 mM Tris-HCI buffer (pH 7.6), 20 mM KCI, 10 mM MgCl2, 
1.5 mM ATP, 1 mM DTI, 0.3 mM NADH, 0.5 mM PEP, 3 units pyruvate kinase, 3 
units lactic dehydrogenase, 1.5 µg of the enzyme and 30 µI of the substrate in a final 
volume of 300 µI. The substrate concentrations varied between O µMand 250 µM for 
pantetheine and between 0 µM and 500 µM for N-pentylpantothenamide. The 
decrease in NADH concentration was measured at 340 nm over a period of 5 
minutes. All measurements were taken in triplicate. 
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4.4.4.2 EcCoaD and CBDEcCoaD 
Each assay contained 60 µI pyrophosphate reagent (Sigma, P7275), 50 mM Tris-HCI 
buffer (pH 7.6), 20 mM KCI, 10 mM MgCb, 1.5 mM ATP, 1.5 mM OTT, 1.5 µg of the 
enzyme and 15 µI of substrate in a final volume of 150 µI. The 4'-
phosphopantetheine concentration varied between 0 µM and 1 mM. The decrease in 
NADH concentration was measured at 340 nm over a period of five minutes. 
Triplicate measurements were taken for each substrate concentration. 
4.4.4.3 EcCoaE and CBDEcCoaE 
The same assay was used as with CoaA, but with 3'-dephospho-CoA as substrate 
varying in concentration between 0 µM and 4 mM. All measurements were taken in 
triplicate. 
4.4.4.4 SaCoaE and CBDSaCoaE 
The same assay was used as with CoaA, but with 3'-dephospho-CoA as substrate 
varying in concentration between 0 µM and 2 mM. All measurements were taken in 
triplicate. 
4.4.5 Determining the binding capacity of the cellulose 
Cellulose (100 mg) was weighed of in 2 ml Eppendorf tubes. The cellulose was 
washed twice with phosphate buffer (20 mM, pH 7.4) containing NaCl (0.5 M), by 
inverting the tubes. The buffer was removed before adding the protein. The tubes 
were incubated at room temperature for one hour to allow immobilization of the 
protein and then spun down to collect the loaded cellulose. 
The concentrations of the enzymes in the supernatants were determined with a 
Quick Start Bradford protein assay (Bio-Rad). This was then taken as the 
concentration of the free protein and was subtracted from the initial protein 
concentration to determine the amount of immobilized protein per mass cellulose. 
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4.4.6 Comparing reactivity of native and fusion proteins over time 
Each assay was conducted with the native enzyme combination, the fusion proteins 
in solution and the fusion proteins immobilized on cellulose. 
4.4. 6. 1 Native proteins and CBD proteins in solution 
4.4.6.1.1 CoA biosynthesis 
Each assay contained 150 mM Tris-HCI (pH 7.6), 15 mM MgCb, 5 mM ATP, 2 mM 
OTT, 25 µg of each enzyme (EcCoaA, EcCoaD and SaCoaE) and 0.5 mM 
pantetheine in a final volume of 500 µI. Aliquots (80 µI) were taken at specific time 
intervals. The protein was precipitated at 95°C for five minutes, and then the aliquot 
was centrifuged for 5 minutes at 8 000 rpm. The assay was repeated with the fusion 
proteins. 
4.4.6.1.2 Ethyldethia-CoA biosynthesis 
Each assay contained 150 mM Tris-HCI (pH 7 .6), 15 mM MgCb, 5 mM ATP, 25 µg of 
each E. coli enzyme (EcCoaADE) and 0.5 mM N-pentylpantothenamide in a final 
volume of 500 µI. Aliquots (80 µI) were taken at specific time intervals. The protein 
was precipitated at 95°C for five minutes, and then the aliquot was centrifuged for 5 
minutes at 8 000 rpm. The assay was repeated using the fusion proteins instead of 
the native enzymes. 
4.4.6.2 Immobilized fusion proteins 
Cellulose (2 mg) was weighed of in 2 ml Eppendorf tubes and washed twice with 
binding buffer (20 mM phosphate buffer, 0.5 mM NaCl, pH 7.4 ). The fusion protein 
(30 µg) was added to the cellulose and the mixture was incubated at room 
temperature for 1 hr. It was washed again with binding buffer to remove all the un-
immobilized enzymes before making the volume up to 100 µI. The 3 x 100 µI 
containing the three required fusion proteins for a specific reaction were combined 
and the rest of the reaction mixture was prepared in 200 µI to make up the final 
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reaction volume of 500 µI. The rest of the reaction mixture was identical to that used 
for the native enzymes. The same assay conditions were used as before. 
4.4.6.3 Conditions for HPLC analysis 
Analyses were done with 25 µI of a sample containing 60µ1 of the reaction mixture 
and 12 µI of a 6 mM guanosine solution (0.5 M HCI) as an internal standard. The 
analysis method took 20 minutes starting with 95% of a 100 mM Phosphate buffer 
solution (pH 6.5) and 5% Methanol. The methanol concentration increased from 5% 
to 30% between 3 and 10 minutes and then it ran isocratic up to 20 minutes. There 
was a 5 minute post run to re-equilibrate the column before the next injection. 
Absorption was monitored at 254 nm. The retention times were: ATP, 3.6 min; ADP, 
3.8 min; AMP, 4.8 min; internal standard, 8.6 min; Coenzyme A, 9.3 min; Ethyldethia-
CoA, 14.4 min. 
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Construction of a Continuous Bioreactor for the Chemo-
enzymatic Synthesis of CoA analogues 
5.1 Introduction 
The aim of this project was to employ immobilized CoA biosynthetic enzymes in the 
construction of a bioreactor for the enzyme assisted transformation of pantetheine 
analogues to their related CoA analogues. In the previous two chapters we have 
discussed the preparation and characterization of these required enzymes. We have 
therefore gathered all the necessary tools and information required to attempt the 
construction of such a reactor. 
In this final· experimental chapter we address the construction of a batch and a 
column reactor. The batch reactor was developed specifically to test the stability of 
the immobilized fusion proteins while the column reactor was used to test the 
productivity of the reaction. Finally, we also attempted the purification of the column 
product. These results allowed us to identify various potential problem areas which 
may be addressed in the optimization of this system. 
5.2 Results and Discussion 
5.2.1 Preparing CoA analogues using a batch reactor: Stability tests 
The first system that we developed was a batch reactor. The purpose of this reactor 
was to test the stability of the immobilized fusion proteins over the course of a few 
days. We chose two substrates for the testing of the batch reactor; N-
pentylpantothenamide, which has been used in the previous studies, as well as a 
fluorescent pantothenamide analogue 5.1 ( 1). Compound 5.1 was synthesized 
according to the method described by Clarke et. al. (2). We specifically chose 5.1 
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since its related CoA analogue 5.2 has previously been used for the successful in 
vivo protein labelling of an acyl carrier protein (Chapter 2). Thus it is a perfect 
example of the kind of analogue which we are aiming to produce by the development 
of this new method (Figure 5.1 ). 
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Figure 5.1: The two biosynthetic reactions that were used to test operation of the batch 
reactor. N-pentylpantothenamide is transformed to ethyldethia-CoA. The coumarin based 
pantothenamide (5.1) is transformed to its corresponding fluorescent CoA analogue (5.2). 
We conducted 1500 µI batch reactions containing 250 µg of each of the three E. coli 
CBD-fusion proteins pre-immobilized on cellulose. The loaded cellulose was kept in 
suspension for the duration of the reaction to ensure that all the substrate came into 
contact with the necessary enzymes. The reactions were initiated by the addition of 
5 mM of the respective substrates and incubated for 90 min at 37°C. After analyzing 
the supernatant for product formation by HPLC analysis the cellulose was thoroughly 
washed and stored overnight at 4°C. An internal standard (guanosine) was co-
injected with all the HPLC analyses to allow for the comparison of the yields of the 
various reactions (Figure 5.2). The reaction was repeated over a period of six days 
using the same cellulose system. All HPLC analyses were done in triplicate. 
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Figure 5.2: Evaluating the stability of immobilized CBD-fusion proteins. The yields of two batch 
reactions are presented over a period of eight days. Each data point represent the average of three 
reaction yields determined for the biosynthesis of ethyldethia-CoA ( +) and 5.2 ( •) after stating with 5 
mM of the required substrates. 
The results show that this method was not ideal for stability testing, as the yields of 
the reactions, as determined by the HPLC analyses, always seemed to be in excess 
of 100%. This may be due to the fact that it was very difficult to remove all of the 
product from the cellulose by washing, which would leave a small amount of product 
behind that would falsely inflate the amount of product determined the next day. 
Another problem with this method was when taking aliquots from the reactions for 
analysis we always collected some of the cellulose as well. The amount of protein in 
the reactions therefore did not remain constant for the duration of the test. 
In spite of these problems we can conclude from this study that the immobilized 
enzymes did not lose much activity for a period of at least six days. 
5.2.2 Preparing CoA analogues using a column reactor: Productivity 
tests 
To determine the productivity of a system using immobilized biosynthetic enzymes for 
the production of CoA analogues we decided to develop a column reactor. However, 
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there are a great number of variables to consider in such a system. We therefore 
had to determine what our operating parameters were going to be before starting the 
experiment. The parameters we considered included: 
• Temperature 
• pH 
• Column dimensions 
• Flow rate 
• Amount of each enzyme 
• Packing of the enzymes 
• Substrate concentration 
The conditions we decided to use for our first attempt at constructing the column 
reactor was based on the conditions we used in the conduction of the assays 
discussed in the previous two chapters. We decided to use 0.5 mM of the 
fluorescent pantothenamide 5.1 as substrate in a 50 ml reaction. A pH of 7.4 and a 
constant temperature of 37°C were chosen. We decided to used equal amounts (330 
µg) of each of the three E. coli CBD-fusion proteins, thus we had a total mass of 990 
µg of loaded cellulose that we needed to pack into the column. Protein-free cellulose 
was added to this mixture to obtain a final column volume of -5 ml. This was packed 
into a column with dimensions 10 mm x 50 mm. To obtain a reaction time of. about 
100 min the reaction mixture was pumped through the column at 0.5 ml/min, giving a 
residence time of about 10 min (Figure 5.3). 
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cellulose 
Figure 5.3: Schematic representation of the column reactor. A reaction mixture containing 0.5 
mM 5.2, 1.65 mM ATP 10 mM Mg2+ and 50 mM Tris (pH 7.6) is pumped through the cellulose column • 
at 0.5 ml/min. The cellulose was loaded with equal amounts of CBDEcCoaA, CBDEcCoaD and 
CBDEcCoaE. Product 5.2 was collected and analyzed on HPLC. 
After conducting the reaction a fraction of the product mixture was analyzed by HPLC 
to determine the percentage transformation that had occurred. This was compared 
to an HPLC of the starting reaction mixture (Figure 5.4, top panel). Two new peaks 
were visible in the product chromatogram. The one was identified as the expected 
product 5.2, while the other was identified as the dephospho-CoA analogue of the 
product. The peak corresponding to the substrate had disappeared and there was 
no peak corresponding to the 4'-phosphopantetheine analogue, thus all the substrate 
was transformed to either 5.2 or the dephospho-CoA analogue. By co-injecting an 
internal standard (guanosine) with each sample we could determine the ratio 
between the product and the dephospho-CoA analogue as 9: 1 (Figure 5.4, bottom 
panel). 
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Figure 5.4: HPLC analyses of the column reactor. Analysis of the reaction mixture (Top) . Analysis 
of the product mixture (Bottom). Retention times: substrate (5.1), 20.8 min; product (5.2) 7.3 min; 
dephospho-CoA analogue 9.6 min . 
To determine the reproducibility of the system we repeated the reaction one week 
later using the same column. Again the substrate peak was absent when the product 
was analyzed. We did however observe a decrease of ca. 7% in the ratio between 
the dephospho-CoA product and 5.2 (Figure 5.5). 
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Figure 5.5: Product of the second column reaction. The ratio between the 5.2 and the de-
phospho-CoA analogue is 83:17. 
The results obtained from the biosynthesis reactions conducted on the column 
reactor have proved that this system can be used continuously, with good 
reproducibility for the preparation of various CoA analogues. 
5.2.3 Purification of the column product 
In the currently available solution-based methods for the preparation of CoA 
analogues large amounts of cellulose are destroyed during the work-up of the 
product. Our column-based method now presents a way to overcome this major 
drawback since the proteins stay immobilized on the column while the product is 
collected as the column elutes. Thus all that needed to be done to obtain the pure 
product from the column reaction was to separate the remaining ATP from the 
product mixture. 
We attempted this separation by using a pre-packed C18 SPE cartridge. The column 
was first activated with methanol and then equilibrated with an NH40Ac buffer (10 
mM, pH 6) solution. After loading the product mixture onto the cartridge the majority 
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of the ATP was removed with a 3% acetonitrile buffer solution (Figure 5.6). The 
product was removed with a 40% acetonitrile buffer solution and the ratio between 
5.2 and the dephospho-CoA peaks remained unchanged by the procedure. We do 
however see the appearance of a shoulder in the product peak. We expect this to be 
iso-CoA analogue of 5.2 formed by isomerization of the product as we have seen 
similar results in previous reactions . However, this still needs to be confirmed 
analytically. 
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Figure 5.6: Purification of the column product. About 96% of the ATP has been removed . The 
ratio between 5.2 and dephospho-CoA has stayed unchanged by the purification procedure. 
5.2.4 Construction of an optimized column reactor 
The results presented above indicate that immobilized enzymes can be successfully 
employed in a bioreactor for the synthesis of CoA analogues. However, it is clear 
that the construction of such a bioreactor will have to be optimized, and studies are 
currently ongoing to determine the optimal operating parameters for the system. 
One of the key pieces of information required to prepare an optimized column is the 
ratio of the three proteins. As to date we have used equal amounts of the three CoA 
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biosynthetic enzymes to prepare the CoA analogues. We do however need to 
consider the specific activities of these enzymes to determine the optimal ratio 
between these proteins that is needed to achieve a 100% conversion of the 
pantetheine derivatives. 
We therefore determined the specific activities of E. coli fusion proteins EcCoaA, 
EcCoaD and EcCoaE (Table 5.1 ). This data show that if one wanted to use equal 
amounts of activity (not weight), these proteins would have to be used in a ratio of 
1 :11 :5. This information will be used in the next attempt at the construction of a 
column reactor. 
0 
Substrate Specific Activity (µg.µmor1 .min-1) 
N -pentylpanothenamide 
EcCoaA 395 
CBD-EcCoaA 430 
pantetheine 
EcCoaA 404 
CBD-EcCoaA 294 
4'-phosphopantetheine 
EcCoaD 2500 
CBD-EcCoaD 3165 
dephospho-CoA 
EcCoaE 5319 
CBD-EcCoaE 1359 
SaCoaE 12500 
CBD-SaCoaE 13889 
Table 5.1: Specific activities of the enzymes that were identified for the production of CoA and 
its analogues. 
87 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 5 - Construction of a Continuous Bioreactor 
5.3 Conclusion 
We have managed to construct two enzyme-based bioreactors for the preparation of 
CoA analogues. By experimenting with these reactors we have shown that stability 
is achieved by immobilizing the biosynthetic enzymes on cellulose and that good 
productivity and reproducibility can be attained. Research is still ongoing to optimize 
the operating conditions of the column reactor, but we have already succeeded in the 
object of this thesis by proving that this method can be used for the more efficient 
synthesis of CoA analogues. 
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5.4 Experimental Procedures 
5.4.1 Materials and Methods 
A high performance liquid chromatography (HPLC) instrument (Agilent 1100 series) 
was used for the analysis of the biosynthetic reactions. All analyses were done using 
a Supelcosil™ LC-18-T 5 µm column (25 cm x 4.6 mm) with a Supelguard™ LC-18-T 
guard column purchased from Supelco. Purification of the column product was 
conducted on a 10 g pre-packed C18 SPE cartridge purchased from Strata. 
Centrifugation was conducted on a Heraeus Biofuge pico centrifuge. 
All the chemicals that we used were purchased from Aldrich or Sigma and are of the 
highest quality. The fusion proteins were immobilized on Avicel PH-101 purchased 
from Fluka. 
• 
5.4.2 Batch reactor 
5.4.2. 1 Immobilization of the fusion proteins 
500 mg of an over-expression pellet was dissolved in 10 ml phosphate buffer (25 
mM) containing EDTA (1 mM, pH 7.4). The cells were disrupted by sonication and 
centrifuged at 15 000 x g for 20 minutes. The supernatant was added to cellulose in 
2 ml Eppendorf tubes in a ratio of 10 µg of enzyme to 10 mg of cellulose. 
The tubes were incubated at room temperature for 1 hour after which it was 
centrifuged at 2 500 rpm for 5 minutes to collect the cellulose. The supernatant was 
removed and the loaded cellulose was washed twice with the same phosphate 
buffer. The washed cellulose was re-suspended in 500 mM Tris-HCI buffer (pH 7 .6) 
containing 10 mM MgCl2. 
5.4.2.2 Reaction mixture 
Each 1500 µI batch reaction mixture contained 50 mM Tris-HCI (pH 7 .6), 10 mM 
MgCl2, 16.5 mM ATP and 250 µg of each immobilized enzyme and 5 mM substrate. 
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The two substrates that were used were N-pentylpantothenamide and the coumarin 
pantetheine derivative (5.1 ). The reactions were incubated· for 90 minutes at 37°C, 
while shaking, and then centrifuged at 5 000 rpm for 1 minute before 30 µI aliquots 
were collected. The aliquots were boiled at 95°C for 5 minutes to insure that the 
reactions were quenched. The aliquots were centrifuged again, to collect any 
precipitated protein-. 
5.4.2.3 Conditions for HPLC analysis 
The injection volume for each analysis was 25 µI. Each sample contained 60 µI of a 
ten time's dilution of the reaction mixture and 12 µI of a 6 mM guanosine solution (0.5 
M HCI). Two different methods were used for the analysis of the two substrates . 
5.4.2.3.1 Biosynthesis of ethyldethia-CoA 
.. 
The method used for the analysis of the biosynthesis of ethyldethia-CoA took 20 
minutes starting with 95% phosphate buffer solution (100 mM, pH 6.5) and 5% 
methanol. The methanol concentration increased from 5% to 30% between 3 and 10 
minutes and then it ran isocratic up to 20 minutes. The retention times were: ATP 
3.4 min; ADP 3.7 min; AMP 4.7 min; guanosine 8.6 min; ethyldethia-CoA 14.4 min. 
5.4.2.3.2 Biosynthesis of fluorescent CoA analogue 5.2 
The method used for analysis of the coumarin CoA analogue took 25 minutes 
starting with 90% phosphate buffer solution (100 mM, pH 6.5) and 10% methanol. 
The methanol concentration increased from 10% to 35% between 3 and 5 minutes 
and then it ran isocratic up to 25 minutes. The retention times were: ATP 3.1 min; 
ADP 3.2 min; AMP 3.6 min; guanosine 6.2 min; coumarin CoA analogue 24 min. 
5.4.3 Column reactor 
5.4. 3. 1 Preparing the column 
CBDEcCoaA, CBDEcCoaD and CBDEcCoaE were immobilized on cellulose in 
separate tubes using the same procedure as described for the batch reactions. 330 
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mg of each enzymes was immobilized on 330 mg of cellulose, thus the total mass of 
loaded cellulose used to pack the column was 990 mg. The three batches of loaded 
cellulose were combined and clean cellulose was added to obtain a volume of -5 ml. 
This mixture was suspended in Tris-HCI buffer (50 mM, pH 7.6) containing MgCb (10 
mM) and loaded into a glass column. The final dimensions of the packed column 
were 10 mm x 50 mm. The column was connected to a pump and equilibrated with 
50 ml Tris-HCI buffer (50 mM, pH 7.6) containing MgCb (10 mM), at a flow speed of 
0.5 ml/min. 
5.4.3.2 Reaction mixture 
A 50 ml reaction mixture containing 50 mM Tris-HCI (pH 7.6), 10 mM MgCb, 1.65 
• mM ATP and 0.5 mM substrate 5.1 was pumped through the equilibrated column at a 
flow speed of 0.5 ml/min while keeping the temperature constant at 37°C. 
5.4.3.3 Conditions for HPLC analysis 
The sample prepared for analysis contained 60 µI of the product mixture and 12 µI of 
the internal standard. A sample containing the reaction mixture was prepared in the 
same way. Both samples were analyzed with the same method used for analyses of 
the batch reaction products. The retention times were: ATP/ADP 0.8 min; guanosine, 
2.2 min; coumarin CoA analogue (5.2) 7.3 min; dephospho-CoA analogue, 9.6 min; 
coumarin pantetheine analogue 20.8 min. 
5.4.3.4 Purification of the column product 
A pre-packed C18 SPE cartridge was used to separate the CoA analogue 5.2 from 
the remaining ATP. The column was activated with MeOH and washed with 1 OmM 
NH40Ac (pH 6) buffer solution before being equilibrated with a 3% MeCN buffer 
solution. The product was loaded onto the column and the ATP was removed with a 
3% MeCN buffer solution. The product was removed with a 40% MeCN buffer 
solution. The purified product was analyzed by the same HPLC method used to 
analyze the crude product. 
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Conclusion 
6.1 Overview of achievements 
CoA analogues are valuable research tools due to the wide variety of biological 
processes in which natural CoA are involved. Therefore, various methods have been 
developed to prepare these analogues. This study was aimed at developing a new 
chemo-enzymatic method utilizing immobilized CoA biosynthetic enzymes to 
construct a reactor that will allow more efficient preparation of the currently etailable 
analogues. 
In pursuing this aim we successfully constructed six novel CBD-fusion proteins. 
CoaA, CoaD and CoaE from E. coli and S. aureus were each fused with a CBD 
domain to allow their immobilization on· cellulose. We confirmed the activity of all six 
the fusion proteins and then put together all eight possible enzyme combinations and 
tested them for the preparation of CoA and ethyldethia-CoA, an E. coli 
antimetabolite. By comparing the activities of the combinations we identified two 
combinations that would be used for the construction of a bioreactor. 
There were four enzymes represented by these combinations. We successfully 
characterized and immobilized them on cellulose and proved that immobilization 
caused an increase in the reaction rate of the combinations of biosynthetic enzymes. 
The three E. coli enzymes, representing one of the identified combinations, were 
used to construct a batch and a column reactor. Results from the operation of the 
batch reactor showed that the immobilized enzymes possess stability that allows 
repeated use of the system. We also proved that yields of up to 90% could be 
achieved by the operation of the column reactor. 
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6.2 Future work 
6.2.1 Optimizing enzyme usage 
At the end of chapter 5 we have commented on current efforts to optimize the 
operation of the column reactor concerning the specific activities of the CBD-fusion 
proteins. These studies are still ongoing. We are also aiming to experiment with 
different ways of packing the immobilized enzymes in the column. To date we have 
only used mixtures of the enzymes when the packing of the column. We also want to 
construct a reactor with the enzyme packed in consecutive layers to see if we can 
decrease the formation of dephospho-CoA and thus optimize the yield of the 
reaction. 
• 
6.2.2 ATP regeneration 
ATP is an essential cofactor in the biosynthesis of CoA. It is also very expensive. If 
we could immobilize a recycling system for this cofactor on the column reactor it 
would however not only decrease the production cost of the analogues, but also 
simplify purification of the product. ATP can be regenerated from ADP by any of the 
four methods presented in Figure 6.1 ( 1). 
The efficiency of these systems and the feasibility of their immobilization also using 
the CBD technology are two concepts that needs to be investigated achieve full 
efficiency of our newly developed chemo-enzymatic column-based bioreactor. 
94 
Stellenbosch University  https://scholar.sun.ac.za
reactant 
donor 
donor 
0 
HO~ 
o'».-J/o 
I bH 
70!J:laton \ 
ATP ADP 
4~~ 
ATP-regeneration 
acetate kinase 
pyruvate kinase 
carbamate kinase 
carbamate kinase 
or acetate kinase 
Chapter 6 - Conclusion 
product 
phosphorylated donor 
phosphorylated donor 
<;? 0 Ho--Pi'--o~ 
OH 
0 ~,.OH 
0,. 'OH 
~o-
o 
Figure 6.1: ATP regeneration. A schematic representation of an ATP recycling system (Top panel). 
The systems currently used for ATP regeneration (Bottom panel). 
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6.3 Conclusion 
This thesis presents the successful development of a new chemo-enzymatic method 
for the preparation of CoA and its analogues. Although much research is still in 
progress to optimize the operation of the newly constructed column reactor we are 
positive that this method already is a significant improvement compared to the 
currently available solution-based methods. 
We have introduced a re-usable system by immobilizing the CoA biosynthetic 
enzymes on cellulose. We also simplified product purification compared to the 
available solution-based methods, by keeping the enzymes separated from the 
product through their immobilization. Construction of the column n;wctor further 
allows continuous production of CoA analogues and should eventually allow large 
scale versions of these reactions. 
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